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EXECUTIVE SUMMARY 
 
As part of a Department of Justice, U.S. Attorneys Office grant for the analysis and evaluation of 
participation in the Prescription Monitoring Program (PMP), the Margaret Chase Smith Policy Center 
mapped and analyzed spatial patterns of prescriber and pharmacy locations as well as PMP participation, 
and conducted a survey of licensed prescribers and dispensers of controlled substances in Maine.  The 
PMP, implemented beginning July 1, 2004, monitors all drugs in Schedules II, II, and IV, and any 
pharmacy that is licensed to dispense prescriptions in or into the state of Maine is required by law to 
report to the program.  Prescribers receive automatic reports from the system about patients who exceed 
a threshold level of activity: prescribers, dispensers, or prescriptions.  In addition, prescribers and 
pharmacists are encouraged to sign up to use the online system that allows them to check patient 
activity; participation is voluntary.  Not all dispensing is tracked.  Hospital inpatient dispensing data and 
data from veterinarians are not collected.  Clinics that offer methadone assisted therapy for addictions 
do not participate.   
On January 5, 2009, the PMP opened a new web portal for their online system and participants 
were asked to re-enroll.  As of June 9, 2009, 149 Data Submitters are registered to submit data for 403 
pharmacies; and 1,197 Prescribers and 138 Dispensers of controlled substances in Maine are currently 
registered with the service to access online information on their own patients. 
Prescriber and Dispenser Spatial Distributions: GIS Findings 
 Using de-identified datasets extracted for each of the fiscal years FY2005 through FY2008 by 
PMP contractor Gould Health Systems (GHS), we examined spatial patterns associated with prescribing, 
dispensing, and PMP participation.  A Geographic Information Systems (GIS) approach revealed the 
location of patients, prescribers and pharmacies that generate and dispense Maine prescriptions, as well 
as the distribution of prescribers who are enrolled in the online PMP.  
The spatial analysis revealed a substantial amount of interstate activity.  In FY2008, there were 
2,276,321 prescription records that had valid location data for 18,444 prescribers (physicians, nurses, 
dentists, podiatrists). The vast majority (95%) of the prescriptions were written by 5,478 Maine-based 
prescribers, who constitute only 29% of the 18,444 total of unduplicated prescribers in the database.  
Thus 71% of the unduplicated prescribers of prescriptions for controlled substances filled in Maine are 
based outside Maine. Similarly, in FY2008, the dataset had 2,339,032 prescription records for which we 
had valid patient location data.  Maine’s 547,650 unduplicated patients comprise 97% of the total 
562,471 unduplicated patients for whom Maine-filled prescriptions were written; 14,821 (3%) of the 
patients were from outside the state, with New Hampshire and Massachusetts contributing more out-of-
state patients and prescribers than other states. 
The numbers of both in-state and out-of-state patients, prescriptions, and prescribers have 
increased every year since FY2005.  Between FY2007 and FY2008 the total number of prescriptions 
filled for Maine patients increased 9%, although the proportion, stayed about the same, 99% 
prescriptions and 97% unduplicated Maine patients.  The number and percent of out-of-state prescribers, 
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however, increased by 1176 (10%).  Most of the Maine-filled prescriptions written by out-of-state 
prescribers (90%) in FY2008 were written for Maine patients.  Likewise, the majority (56%) of the 
Maine-filled prescriptions written for out-of-state patients in FY2008 were written by Maine prescribers.   
Nevertheless, 71% of prescribers encountered by PMP pharmacies (the data submitters) are from 
out-of-state.  This likely contributes to missing and erroneous data that may be of concern.  For 
example, in FY2008, when we checked several high-frequency drugs, prescriptions for methadone 10 mg 
(but not Adderall XR 20 mg, APAP/Codeine Tab 300/30, or Lorazepam 1 mg tab) were significantly 
more likely than other types of prescriptions to have invalid or missing prescriber location data. In 
FY2008 13% of prescribers lacked valid location data. When a sample of prescription transactions from 
the 3rd quarter of FY2008 were sampled by GHS, 9% of prescriber DEA numbers were invalid.  
 Our GIS mapping research focused particular attention on registration rates by prescribers in the 
on-line PMP, normalized within Healthy Maine Partnership (HMP) areas, which are smaller than 
counties and often organized around hospitals or other medical provider organizations.  Rates were 
adjusted for population density, prescriber density, and prescription density.  We also analyzed the 
increase/decrease seen between FY2007 and FY2008.   
The absolute number of registrants increased in most HMP areas, with some HMPs increasing 
about 50% in the HMP associated with Cary Medical Center and the Ellsworth-Mt. Desert Island area, as 
well as the HMPs in the southern quarter of the state., When calibrated according to population density, 
the highest rates of participation were seen in the Bangor, Augusta-Waterville, and Waldo County HMP 
areas, with the area Portland south having lower rates.  When we mapped participation rates according 
to the number of prescribers located in each HMP, we found percentages above 50% in some areas: 
Wiscasset, Machias, Sebasticook Valley, Dover, Lincoln, and northern Aroostook County; lower rates 
are seen in the Bangor, Calais, and Portland areas.   
 We measured prescription density per 100,000 population, as well as prescriber density per 
100,000 population, as an indicator of potential PMP need (and impact).  The areas for greatest potential 
need (and greatest potential pay-off for PMP marketing) were in the Bangor, Waterville, Lewiston-
Auburn, and Portland.  When we looked at the density of prescribers per 100,000 prescriptions, 
indicating higher potential PMP participation volume, we found that prescriber density is greatest in the 
Kittery, Bangor, and Ellsworth area: fewer prescriptions per prescriber, but relatively more prescribers 
to recruit.  Conversely, recruiting prescribers in the Lincoln and Sebasticook areas would impact a 
greater proportion of prescriptions. 
  
Survey of Prescribers and Pharmacists 
Survey participants were recruited using address lists obtained through state licensing boards, 
and all 6,753 potential participants were mailed questionnaires from May 19-29, 2009.  As of July 10, 
2009, 1,352 questionnaires have been received: 203 (18.9% of distributed) completed the Pharmacist 
Survey, and 1,101 (20.2% of distributed) completed the Prescriber Licensee Survey. Questions in the 
survey focused on two aspects of the PMP, the threshold reports and use of the online PMP system. 
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Pharmacist Survey 
Of the 203 pharmacists who completed the Pharmacist Survey, about half (51.7%) practice in 
pharmacy chains, 21.7% practice in hospitals, and 14.8% are independent.  The vast majority, 192 
(94.5%) dispense controlled substances: our analysis focuses on those respondents.  Of these, 80 
(41.7%) pharmacist respondents are enrolled to use the online PMP, 58.0% of the 138 pharmacist 
enrollees in OSA’s records.  Although 80 are enrolled, only 55 (68.7%) respondent enrollees say they 
are actually using the online PMP. 
Of the 128 of pharmacist responders who have not registered with the PMP, 60.9% have never 
attempted to enroll, 22.6% do not have internet access at work, 14.1% are unsure how to use PMP, and 
11.7% commented that their own computer network problems and/or organization policy barriers 
precluded their registration.  Of those 55 pharmacists who are enrolled online with PMP, if a pharmacist 
finds through the PMP that a patient is receiving prescriptions from multiple providers, he/she will 
“usually/always” look up the patient’s history (62.0%), call other prescribers (52.9%), and/or add the 
information to the patient’s file (52.2%).  
Suggestions for improvement were received from 67 pharmacist respondents.  The most common 
responses were: there should be better education about and awareness of the program (16.2%), the new 
interface was too cumbersome and logging in was difficult (16.2%), and make the information more “up-
to-date” (14.7%).  Selected key informant interviews of three pharmacists representing chains and an 
independent pharmacy revealed that using the PMP may take as long as 5-6 minutes per patient.  They 
commented that the post-January design is a bit faster.  .  The second problem, and one for which they 
see no apparent solution, is that the data are at least two weeks old.  Nevertheless they see the PMP as 
very necessary and helpful.   
We examined pharmacy types (chain, independent, and other)1 in terms of PMP registration patterns and 
reasons for non-use of the PMP.   We grouped the reasons respondents selected for not registering with or using 
the PMP into three categories: those related to training, design changes, or organization policy issues.  We found 
that there is no statistically significant difference among the respondents from these three types of pharmacies or 
in terms of whether pharmacist respondents have ever registered or re-registered, in terms of (a) whether the 
respondent selected organizational issues as a reason for non-use or non-registration, (b) selected training issues, 
or (c) selected design issues.   
Prescriber Survey 
Of the 1101 Prescriber Licensee Survey respondents who are currently licensed in Maine to 
prescribe controlled substances, 127 (11.5%) do not prescribe controlled substances (“Non-
Prescribers”); they were removed from the analysis.  The primary focus of this report addresses the 974 
Prescriber Licensee Survey respondents who have prescribed controlled substances to at least 1% of 
their patients within the previous year (“Prescribers”).  Findings for Prescribers who write scripts for 
controlled substances are reported in three groups: “Not Registered with the PMP (Q6), “Registered/Do 
Not Use the PMP (Q7),” and “Registered/Use the PMP (Q8).” When all licensees are considered 
together, almost half of respondents (48.9%) are not registered with the PMP, 16.1% are registered but 
do not use the PMP and 34.1% are registered and use the PMP online service.  
                                            
1 Hospital pharmacies were removed from this analysis. 
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The most common reasons cited for non-enrollment include they "never attempted to enroll" 
(72.3%) and they are "unsure how to use PMP system" (18.1%).  Of the 85 respondents who expanded 
on reasons for non-enrollment, 36.5% did not know about the PMP or had forgotten about the program. 
Of the sixteen percent who are registered with the PMP but do not use the online service, more 
than one in three (39.4%) had forgotten their user name and/or password, 30.0% were unsure how to use 
the PMP system, and 25.0% stated it was inconvenient to have timely access.  A substantial number 
(41.7%) of these respondents who provided comments said the PMP did not apply to their practice or 
they had too few patients for whom they prescribed controlled substances. 
A total of 294 (34.1%) of those respondents who write scripts for controlled substances are 
registered for and use the PMP. These respondents “usually/always” use the PMP to check suspicions of 
doctor shopping (47.3%), and “occasionally” check to monitor a current patient (61.3%) or to check 
history for a new patient (44.3%).  If they find that a patient is receiving prescriptions from multiple 
providers, over half (54.5%) “very rarely/never” discharge the patient.  They “occasionally” call the 
pharmacist (50.0%) or refer the patient to a licensed substance abuse treatment professional (48.3%).  
These respondents “usually/always” look up the patient history (65.6%), discuss the situation with the 
patient (67.7%), and/or add this information to the patient’s file (76.1%).  
More than half (51.9%) of all 974 Prescriber respondents have received a PMP threshold 
notification report.  After receiving a report, 61.1% of Prescribers state that they “usually/always” add 
this information to the patient’s file, 31.3% discuss the situation with the patient, and/or 29.8% establish 
a controlled substances agreement.  Most of these respondents (68.5%) say they “very rarely/never” 
discharge the patient, call other prescribers listed in the threshold report (65.3%), refer the patient to a 
licensed substance abuse treatment professional (69.8%), or conduct a substance abuse screening and 
brief intervention (53.5%). 
We looked at whether reasons for non-registration or non-use of the PMP could be associated specifically 
with lack of training, or PMP design, or respondent organization policies.  We found that all three of these types 
of issues were significantly associated with non-registration or non-use.  We also examined how years in practice 
might be associated, and found that those with fewer years in practice were signficantly more likely to register 
and use the PMP.  In addition, receiving a threshold report was significantly associated with registration and use. 
 
PMP Use by Practice Specialty 
Six categories of practice specialties were broken out for further examination: Primary Care, 
Nursing, Surgical, Dental, Emergency Medicine, and “All Others.”  The percentages within each 
specialty category that are registered are: 55.7% in Primary Care; 61.6% in Nursing; 31.5 in Surgical 
specialties; 33.1% in Dental specialties; and 83.1% in Emergency Medicine. Of those who have 
registered, the percent of those who use the PMP are as follows: Primary Care 68.6%; Nursing 68.3%; 
Surgical 53.3%; Dental 55.8%; Emergency Medicine 79.3%.   Emergency Medicine respondents are 
more likely to be registered users than any other category, with Nursing and Primary Care specialties 
ranking second and third.  Although more years in practice is associated with non-registration and use in 
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the prescribers considered as a whole population, it is not significantly associated in any of the specialty 
categories taken individually. 
A greater proportion of Surgical (68.5%) and Dental (66.9%) specialties are not enrolled with the 
PMP compared to Emergency Medicine (16.9%) respondents.  Additionally, while Surgical specialty 
respondents prescribe controlled substances at a higher rate than other specialties—35.5% prescribe to 
over 51% of their patients, they are also the group most likely to not be registered with the PMP online 
service. Those in Surgical specialty were more likely (83.8%) to say they had never attempted to enroll 
compared to those in Emergency medicine (36.4%). Those in Nursing specialties (31.3%) and 
Emergency Medicine (27.3%) were more likely to state they were unsure how to use PMP as a reason for 
non-registration than those in Surgical (13.5%) or Dental (10.1%) specialties. 
The most common reasons for non-PMP use among those who have registered include the 
following:  Primary Care (52.5%) and Emergency Medicine (58.3%) respondents were most likely to 
choose “forgot user name or password.”  For Surgical (42.9%) it was “inconvenient to have timely 
access;” for Dental (36.8%) it was “enrolled but have not yet had the opportunity to use PMP;” and for 
All Others (51.4%) it was “unsure how to use the PMP system.”  Dental (31.6%), Emergency Medicine 
(25.0%) and Primary Care (20.3%) respondents were most likely to cite “system design problems at the 
PMP’s end.” Of the 25 respondents who gave comments expanding on these system design problems, 
76.0% cited login or access problems as the reason for not using the PMP service.   
A greater proportion of Emergency Medicine (70.8%) respondents are enrolled and use the PMP 
service compared to Primary Care (55.7%), Nursing (61.6%), Surgical (14.8%) and Dental (20.3%) 
specialties.  Most of the PMP users report occasional use, rather than routine use for current patients. 
Most PMP users in all specialties report they use the system for “1% - 25%” of their patients. While 
Dental (60.9%) and Surgical (50.0%) groups will “very rarely/never” use the PMP to check history for a 
new patient, 45.0% of Emergency Medicine and 44.4% of Nursing groups “usually/always” check.  
Similarly, Dental (36.4%) and Surgical (37.5%) will “very rarely/never” use the PMP to check 
suspicions of doctor shopping, compared to Emergency Medicine (64.3%) and Nursing (54.5%) 
specialties who will “usually/always” check.  
 If a Prescriber finds that a patient is receiving prescriptions from multiple providers, 
respondents will “usually/always” look up patient history in PMP (78.4% Nursing, 70.0% Dental, 65.8% 
Primary Care, 65.0% Emergency Medicine), add this information to the patient’s file (84.7% Primary 
Care, 84.3% Nursing, 75.0% Surgical), and/or discuss the situation with the patient (80.0% Nursing, 
75.2% Primary Care, 67.7% All Others).  Primary Care (62.5%) and Nursing (64.7%) will 
“usually/always” establish a controlled substance agreement. While 50.0% of Primary Care, 41.3% of 
Nursing, and 40.7% of All Others would “occasionally” discharge the patient from the practice, 77.8% 
of Dental specialties say they would “very rarely/never” discharge the patient. 
 
Respondent Comments and Suggestions 
Regardless of whether they use the service or not, a majority of both pharmacists and prescribers 
believe the PMP is a useful tool that needs some tweaking.  When asked how the PMP has affected their 
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practice, 38.5% of pharmacist survey and 64.5% of Prescriber survey respondents who commented gave 
positive responses or examples.  They believe it is a useful, helpful program, and used descriptors like 
“excellent program,” “wonderful,” and “invaluable tool.”  Still, 29.6% of pharmacists and 12.0% of 
prescribers felt that the PMP had done little or nothing for them. 
Prescriber respondents (n=229) gave multiple comments about improving the PMP online 
service:  the PMP is “clunky,” confusing, and not “user-friendly” (34.1%); that login/password 
accessibility is frustrating (17.9%); that information should be more up-to-date (17.9%); and that more 
training/information would be beneficial (10.9%); other states should be included (3.5%); and 
methadone clinics should be included (3.9%). 
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SUMMARY AND RECOMMENDATIONS 
 Following its first four years, Maine’s Prescription Monitoring Program (PMP) has established 
itself as an important vehicle to help pharmacists and prescribers manage medical therapies involving 
Schedules II, III, and IV controlled substances.  The data from 100% of legitimately dispensed Maine 
prescriptions2 is aggregated every two weeks into a searchable database.3  The database is being used by 
an increasing number of pharmacists and prescribers statewide. Prescribers have two types of potential 
links to the PMP.  Medication threshold reports are currently being generated automatically for all 
patients in the system who exceed a threshold number of prescribers, pharmacies, or prescriptions; these 
reports are sent to the prescribers.  Secondly, prescribers as well as pharmacists can enroll to use the on-
line version of the database in order to locate information about their own patients.   
 Analysis of PMP spatial data demonstrates that out-of-state pharmacies, patients, and prescribers 
play a prominent role in Maine’s prescription monitoring system, pointing to the importance of 
developing and collaborating with inter-state PMP data systems.  In FY2008, 71% of the 18,444 
prescribers and 3% of the 547,650 patients in the system originated from outside Maine.  Almost half 
(44%) of the prescriptions written by out-of-state prescribers were written for out-of-state patients (who 
received their prescriptions from Maine-based pharmacies).  Although Maine prescribers constituted 
only 29% of all of the individual prescribers in the system, they were responsible for 95% of the 
2,276,321 prescriptions.   
All states contribute prescribers and patients to Maine’s PMP, but many of those states do not 
themselves monitor prescriptions.  New Hampshire and Florida are important sources of Maine’s PMP 
prescribers and patients, yet neither have functioning PMPs.  Out-of-state PMP prescribers and patients 
are most numerous in states adjacent to Maine, but with fairly high levels of participation from some 
more distant locations, for example New York, Pennsylvania, Florida and California.  Thus, as interstate 
data sharing grows4, Maine’s collaboration with some states will be more important than others. 
Although the vast majority of prescriptions are written by Maine prescribers, the participation of 
out-of-state prescribers (13,095 of them in 2008) is apparently presenting data collection challenges to 
the data submitting pharmacies.  For example, data associated with the out-of-state prescribers more 
often (13% of the time) lacks valid location data; these missing data are significantly more often 
associated with narcotic analgesic prescriptions than those for stimulants and tranquilizers.  And in the 
third quarter of FY2008, 9% of the prescribers in the dataset lacked valid DEA numbers.  A small 
number of the out-of-state prescribers are locum tenens doctors who are filling in locally for vacationing 
physicians or in other staff shortage situations.  But our analysis shows that many more are associated 
with seasonal residents and vacationers.  It is important that the PMP and Maine pharmacies have 
procedures to assure complete data, particularly out-of-state location data and DEA numbers. 
The target population of prescribers and dispensers who could benefit by using the online PMP is 
spread unevenly across the state. Not surprisingly, high participation is localized in areas with more 
                                            
2 Although prescription data from the Veterans Administration is in the FY2004-FY2008 datasets, they will not be submitting 
data in the future. 
3 The system design was updated in January, 2008, requiring re-enrollment to use the on-line database.  The system will soon 
shift to weekly data submissions. 
4 Maine is already taking initial steps to test data sharing concepts. 
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density of population and prescribers, frequently corresponding to the cachment areas associated with 
medical centers.  Spatial analysis of the prescribers who had enrolled in the on-line PMP system showed 
that the spatial distribution and density of participants remained about the same between 2007 and 2008, 
although the number of prescriptions has increased. 
Education about the PMP, and evaluation of participation should be targeted to those who 
actually prescribe (or dispense) these substances.  There is a great deal of variability in the prescriber 
population in terms of their need for PMP information.  Our survey indicates that only 88% of 
prescribers and 95% of pharmacists actually prescribe Schedules II, III, and IV.  And most (75%) 
prescribers prescribe controlled substances to fewer than 25% of their patients.  Primary care (physicians 
and advanced practice nurses) and emergency room physicians tend to use the PMP the most, while 
surgeons and dentists tend to use it much less. Thus some education about the PMP could tailored for 
particular specialties and particular organizations.  Similarly, published enrollment rates could perhaps 
be more fine-tuned to reflect enrollment levels within subsets of prescribers who are already prescribing 
controlled substances, or within certain geographic areas, rather than across all licensees.   
PMP participant engagement should be an on-going process.  Even though prescribers may enroll 
at one point in time, survey results show about a third of enrollees do not use, or stop using, the PMP.  
Enrollees are the potential opinion leaders (and frequently the on-site trainers for their colleagues) 
whose experience is critical to additional recruitment.  On-going engagement and education efforts 
should target this important subpopulation, for example involving them in continuing education, user 
tips, and reminders.  Their experience with the PMP can perhaps provide an education feed-back loop, 
for example through an on-line users group.  Provider organizations which have mandated use of the 
PMP might be interested in becoming PMP trainers for their areas.  Emergency room physicians, 
advanced practice nurses, and primary care physicians are the greatest proponents of the system; be sure 
to keep these and other enrollees in the loop with up with updates, efforts to develop training strategies, 
and continuous improvement. 
Education about the PMP should target enrollees and explicitly address key perceived barriers, 
which span all specialties and license types.  In particular these approaches or training units might 
include:  (a) ‘Speeding up your PMP access process,’ (b) ‘Strategies to keep your user name and 
password handy,’ (c) ‘Retrieving lost passwords,’ (d) ‘What to do if your patient is doctor shopping,’ (e) 
‘Strategies to address patient addiction,’ (f) ‘How to handle suspected drug diversion by a patient,’ (g) 
‘A quick-start refresher in using the PMP,’ (h) ‘PMP use for the computer novice,’ (i) ‘Suggested 
language to use for encounters with difficult patients,’ (j) ‘How to use the PMP to do a quick check on a 
new patient,’ (k) ‘Where to get more training on prescriber practice standards,’ ‘(l) ‘Legal issues 
associated with the state’s Prescription Monitoring Program. 
In targeting those who have not enrolled, consider focused marketing efforts for surgeons and 
dentists.  These approaches include a brief rationale about the benefits (even necessities) of use and 
enhancements recently done to increase speed and efficiency. Target these specialties with language 
addressing them, e.g., ‘Integrating PMP use into your dentistry practice,’ or ‘PMP benefits for 
surgeons,’ or ‘Do dentists need to use the PMP?’  Data about how many minutes a PMP patient check 
actually takes may be helpful. 
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The Maine PMP continues to refine its approaches and its system.  They have recently upgraded 
their data system to improve accuracy and completeness.  The new system also provides for automated 
password recovery.  One problem prescribers in the survey reported was that data were not “up to date.”  
The data submission is increasing to require pharmacies to submit within seven days of dispensing 
starting January 1, 2010. Maine is also collaborating in the development of interstate data sharing. 
Recent statute changes provide for access to the PMP by MaineCare and the Office of Chief Medical 
Examiner.  The PMP will also soon undergo a routine program evaluation. 
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INTRODUCTION 
 
The purpose of this study5 was to collaborate with the Maine Office of Substance Abuse in 
evaluating the Prescription Monitoring Program (PMP), particularly patterns of participation/non-
participation by prescribers and pharmacists in the online service.   The study involved two primary 
components: (1) a geographic information systems (GIS) analysis of spatial characteristics associated 
with prescribing, dispensing, and with participation in the online PMP, and (2) a survey of licensed 
prescribers and pharmacists who were already participating or could potentially participate in the online 
service to access patient data. The following report uses the study findings to describe how prescribers 
are using the information from the threshold reports and the online data as well as to analyze barriers 
and opportunities for expanding PMP participation.   
 The PMP statute was passed by the Maine State Legislature in 2003, and began operation in July 
2004.  This system, which is operated by the Maine Office of Substance Abuse, monitors all drugs in 
Schedules II, III, & IV as described by the Federal Controlled Substances Act (CSA).  Any pharmacy 
licensed to dispense prescriptions in or into the State of Maine is required by law to report to the 
program, with the exception of methadone assisted therapy programs; submissions are due the 15th and 
30th of every month. Currently (June, 2009), 149 Data Submitters are registered to submit data for 403 
pharmacies.  Prescribers themselves do not submit data to the system.  Hospital inpatient dispensing data 
and data from veterinarians are not collected6. 
Each quarter, Patient Threshold Reports are automatically sent to the health care providers 
regarding any patient who exceeds a threshold number of prescribers or pharmacies.  In addition, 
prescribers and dispensers can register for online access to obtain information regarding their own 
patients only.  Licensing boards may use the information for investigations they are conducting; law 
enforcement officials can access the data only through the Attorney General's Office by subpoena for a 
case they are currently investigating. 
The PMP began registration of prescribers and pharmacists to use online access to the database 
in January 2005.  The online interface was updated in January 2009, and participants were asked to re-
register for access to the new system. As of June 2009, 1,197 prescribers (22% of those who prescribe 
controlled substances covered by the PMP (Table 1) and 138 pharmacists (13% of the estimated number 
who dispense controlled substances covered by the PMP) were registered with the service to utilize the 
online PMP to obtain information on his or her own patients.   
 
 
                                            
5 Funded by a grant from the United States Attorneys Office for the District of Maine 
6 PMP website, http://www.mainepmp.org/frequently_asked_questions, accessed 6/12/2009. 
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METHODS 
 
GIS Analysis of Spatial Data Collected as a Function of the PMP 
A de-identified data set was extracted by the PMP contractor, Gould Health Systems, including a 
record for each controlled substance prescription transaction from July 1, 2004, through June 30, 2008 
(Table 1).  
Table 1. Total number of prescription records provided, by state fiscal year 
Fiscal 
Year 
Total Number of 
Records Provided 
by GHS 
Records with Valid 
PATIENT  
Location Data 
Records with Valid 
PRESCRIBER 
Location Data 
Records with Valid 
PHARMACY 
Location Data 
2005 1,878,736 1,878,132 1,866,389 1,868,694 
2006 2,033,619 2,032,817 1,735,895 2,031,334 
2007 2,148,294 2,147,593 2,132,850 2,147,728 
2008 2,339,662 2,339,032 2,276,321 2,286,415 
 
In addition to information about the drug and dose, the dataset includes a pharmacy/pharmacy 
chain identification number, the zip code and state location of the pharmacy, a patient identification 
number (randomly assigned) with associated zip code and state location, a Prescriber identification 
number (randomly assigned), and a zip code and state for the primary address of the Prescriber. 
Prescriber and patient identification numbers are specific to only one fiscal year at a time.  
Our focus with these data was to learn about spatial patterns associated with patients, prescribers 
and pharmacists.  We were particularly interested in the locations of patients, prescribers, pharmacies, 
and the related volume of controlled-substance prescriptions. We imported the data into Arc-GIS v. 9.3 
and produced a series of maps portraying spatial frequency and rate patterns of (a) the dispensers 
(pharmacies/pharmacy chains), (b) the prescribers, and (c) patients associated with prescriptions. Maps 
were done for each fiscal year using a unified scale and legend system, so that years could be compared.   
Preparing Unduplicated Patient, Prescriber and Pharmacy Datasets with Valid Location Data 
In the dataset we were using (e.g., n=2,339,662 records in FY2008), each record was a single 
prescription transaction.  For some analyses, however, we created on an unduplicated count of patients, 
or prescribers, or dispensers (rather than using all the prescription records) and analyzed their locations.  
Unduplicated values from the FY2008 dataset included the following:  562,713 unduplicated patient 
identification numbers; 21,192 unduplicated prescriber identification numbers; and 339 unduplicated 
pharmacy data submitter (NABP) identification numbers.  
We extracted for use only those records for which location data was present.  Since each patient, 
prescriber and dispenser had an unduplicated identification number, we sorted the dataset using that 
field, then selected the first occurrence of each unduplicated identification number in order to do an 
unduplicated count, and utilized the state and/or zip code from that record as the location. Over 97% of 
the records have valid location data (see Table 2). That is, out of 2,339,662 records in the original 
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dataset, 2,286,415 (97.7%) have valid pharmacy locations, 2,276,321 (97.3%) records have valid 
prescriber locations, and 2,339,032 (100.0%, when rounded) have valid patient locations.  Despite the 
high percent of prescription transactions with valid location data, when we analyzed the unduplicated 
patients, prescribers, or pharmacy data submitters, the percent with valid location data was lower for 
prescribers (87%) and pharmacies (85%) (see Table 2). 
 
Table 2. Number of unduplicated patients, prescribers, and pharmacies with location data, by fiscal year 
Fiscal Year 
Number of 
Unduplicated 
Patients 
Number of 
Unduplicated 
Prescribers 
Number of 
Unduplicated 
Pharmacies 
2005 504,042 17,795 284 
2006 517,169 13,796 294 
2007 521,812 19,093 310 
2008 562,471 18,444 289 
 
We removed records for which location data were invalid or missing. If we had the zip code but 
not the state we were able to look up the zip code and insert a state designation.  Sometimes the zip code 
was missing for just the patient, or just the provider, but not both.  Thus, we might be able to include a 
specific record in the patient analysis (for example) but not for the prescriber analysis.   
Table 3. Number and percent of unduplicated records with valid location data in FY20087 
  
Unduplicated Count 
 
Unduplicated Count 
and Percent With 
Valid Location Data 
 
Total Number of 
Associated 
Prescriptions 
 
 
Total Number of 
Associated Maine 
Prescriptions 
 All prescription 
transactions received 
2,339,662 
   
Patient  
Records 
All 
unduplicated patients 
 
 
562,713 (100.00%) 
Patients with valid 
location data 
 
 
562,471 (99.96%) 
All prescriptions 
associated with 
located patients 
 
2,339,032 
 
All prescriptions 
associated with Maine-
located patients 
 
2,311,429 
 
Prescriber 
Records 
All unduplicated 
prescribers 
 
 
21,192 (100.00%) 
Prescribers with valid 
location data 
 
 
18,444 (87.03%) 
All prescriptions 
associated with 
located prescribers 
 
2,276,321 
 
All prescriptions 
associated with Maine-
located prescribers 
 
2,162,701 
 
Pharmacy 
Records 
All unduplicated 
pharmacies 
 
 
339 (100.00%) 
Pharmacies with valid 
location data 
 
 
289 (85.25%) 
All prescriptions 
associated with 
located pharmacies 
 
2,286,415 
All prescriptions 
associated with Maine-
located pharmacies 
 
2,285,576 
                                            
7 The PMP relies on the pharmacies to submit accurate data, but some errors and omissions occur.  When errors 
come to the attention of the PMP, they are corrected, but the PMP does not automatically check for errors. 
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Data submissions and procedures have improved through time, and although all years have 
relatively complete data, the data for FY2008 are more complete than previous years. Some of the 
increase in absolute numbers of prescriptions from year to year may be due to improved quality of 
reporting.  Thus, we were cautious about comparing absolute numbers (e.g., of prescriptions or patients) 
through time. Instead, we focused our year-to-year comparisons on proportions rather than absolute 
numbers.  For example, the absolute number of prescriptions dispensed to out-of-state patients increased 
19% between FY2007 and FY2008, a rather high percentage.  However, we chose to describe the change 
as an increase in the proportion (percent) of prescriptions dispensed to out-of-state patients (see Table 
8), which increased only 9%. 
For PMP Maps 500-502 (Appendix A) we displayed the prescription frequency by the home state 
of the pharmacies, prescribers, or patients.  For PMP Maps 503-505 we unduplicated the prescribers, 
pharmacies, and patients and examined their frequency within their home state.   
In PMP Maps 100,109-115 (Appendix A) we mapped at the state level, as well as the sub-county 
level, the latter by using Healthy Maine Partnership areas.  We selected the Healthy Maine Partnership 
areas because they are more specific than counties and generally associated with hospitals or other 
health care provision infrastructures.  In some maps we display the absolute number of prescriptions (or 
prescribers, pharmacies or patients) for each area.  For others we have converted the frequency data to 
rates per 100,000 persons, or per 100,000 prescriptions.  Associated with each map is a table that 
displays the data behind the spatial patterns.  Statistical analyses were performed using SPSS v. 14. 
It is important to note that machine-assigned identification numbers for (unduplicated) 
prescribers and (unduplicated) patients are specific to each year’s extraction, so patterns associated with 
individual patients or prescribers cannot be followed through time.  Further, the method for linking 
prescriptions to individual (“unduplicated”) patients uses a “fuzzy logic” approach that matches names 
and dates of birth, rather than utilizing a patient’s formal identification number. 
GIS Analysis of Participation in the Online PMP 
The PMP Coordinator provided a de-identified dataset of participants in the online PMP for 
FY2007 and FY2008, localized by zip code.  Because the numbers of participating prescribers in each 
zip code area were small, we aggregated the zip code designations into Healthy Maine Partnership Areas 
(each encompassing multiple zip code areas) in order to examine participation frequencies.  In order to 
explore variation in the spatial distribution of licensed prescribers (e.g., there are more in areas with 
medical centers and in areas with higher population density), we normalized data by converting the raw 
frequencies to rates according to three parameters: the density of prescribers, the population density, and 
the density of prescriptions filled.   
Survey of Prescribers and Pharmacists 
The Prescriber Licensee Survey (Appendix B) was mailed to Maine licensed prescribers of 
controlled substances in May 2009.  A separate Pharmacist Survey (Appendix B) was mailed to licensed 
pharmacists.  Questionnaires were designed to learn about perceived barriers and advantages to using the 
PMP online service.  For those who had registered online, the questionnaire asked how the PMP was 
being used and what impact the PMP had on their practices.  For those who had not registered online, 
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the questionnaire asked for feedback on the PMP and why the service was not being used.  All 
participants were asked to share suggestions for improving the PMP online service.  They were informed 
that survey results would be shared with the Office of Substance Abuse to help improve the program and 
the participation rates. 
Participants were recruited for the mail survey using address lists obtained from state licensing 
boards (Table 4).  These lists were first sent to University of Maine Mail Services for address validation, 
and then distributed through postal mail from May 19 – 29, 2009.  The population was not sampled; 
questionnaires were mailed to all potential participants.  Participants were sent a letter of introduction 
including informed consent (Appendix C), a questionnaire (Appendix B), and a postage-paid return 
envelope.  Medical Doctors (MD), Doctors of Osteopathy (DO), and Physician Assistants (PA) received 
a letter of introduction signed by the principal investigator as well as by the heads of those boards of 
licensure, while other prescribers (e.g., Doctors of Podiatry, Doctors of Dental Surgery, Advanced 
Practice Nurses, and Midwives) and all Registered Pharmacists received a letter signed by the principal 
investigator alone.  Participation was described as voluntary, and consent was implied when participants 
returned completed questionnaires.  Returned questionnaires contained no identifying information other 
than zip code of practice and practice specialty.  The Prescriber Licensee Survey expands on a similar 
questionnaire administered to Maine General Medical Center staff in Fall 2008.   
Table 4: Questionnaire Distribution for Maine Prescribers and Dispensers 
Survey Group 
 
Addresses 
Obtained From 
Original number of 
addresses 
Final mailing after 
address validation 
Dispenser Survey: 
Pharmacist  Agency License Management System (alms) online 1,083 1,075    (99.3%) 
Prescriber Survey: 
Dentist  Maine Office of Data, Research, and Vital Statistics 596 560    (94.0%) 
Midwife Maine State Board of Nursing 75 72    (96.0%) 
Advanced Practice 
Nurse Maine State Board of Nursing 893 870    (97.4%) 
Podiatrist Agency License Management System (alms) online 82 82 (100.0%) 
Medical Doctor Maine Board of Licensure in Medicine 3,325 2,979    (89.6%) 
Doctor of Osteopathy Maine Board of Osteopathic Licensure 771 720    (93.4%) 
Physician Assistant Maine Board of Licensure in Medicine 471 395    (83.9%) 
All Survey Groups:  7,296 6,753 (100.0%) 
Only seven Prescriber questionnaires were returned with “address unknown.” As of July 10, 
2009, 1,352 questionnaires have been completed and returned: 203 (18.9% of distributed) pharmacist 
questionnaires and 1,149 (20.2% of distributed) Prescriber questionnaires.  Forty-one prescribers 
returned their questionnaires, informing us they were retired or not currently licensed in Maine; these 
were removed.  Of the 1,101 total valid Prescriber surveys received, 127 (11.5%) reported that they did 
not prescribe controlled substances. These are designated in this report “non-prescribers,” and are 
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reported on briefly as a separate group.  The final dataset for analysis consists of 974 active prescribers 
of controlled substances in Maine, and 203 pharmacists. This respondent sample is likely not 
representative of all prescribers and dispensers due to a probable non-response bias.   
Analysis and discussion of the survey results is broken into three sections (Table 5), according to 
respondent type: pharmacists (n=203); prescribers who do not write scripts for controlled substances 
(“non-prescribers,” n=127); and prescribers who have prescribed controlled substances to at least 1% of 
their patients within the past year (“prescribers,” n=974). When feasible, respondents are also analyzed 
by the larger categories of self-reported specialties, including primary care physicians; emergency 
medicine physicians; surgeons; nursing; dentists (general dentistry and all other dental specialties); and 
“all others.” 
Table 5.  Distribution of Prescriber Respondent Types by Specialty Categories 
 
Respondents by Specialty Group Non-
Prescribers Prescribers 
Specialty 
Categories 
Total 
Respondents 
in Each 
Specialty 
Group 
Percent 
of 1,101 
Respondents 
 
Non-Prescribers 
Number and 
Percent of 
Specialty Group 
Total 
Not Registered  
with PMP 
Number and 
Percent of 
Specialty Group 
Total 
Registered/ 
Do Not Use PMP 
Number and 
Percent of 
Specialty Group 
Total 
Registered/ 
Use PMP 
Number and 
Percent of 
Specialty Group 
Total 
Primary 
Care*  355 32.2% 19 (5.3%) 149 (44.3%) 59 (17.6%) 129 (38.4%) 
Nursing* 145 13.2% 20 (13.8%) 48 (38.4%) 26 (20.8%) 56 (44.8%) 
Surgical  56 5.1% 2 (3.6%) 37 (68.5%) 7 (13.0%) 8 (14.8%) 
Dental* 125 11.3% 7 (5.6%) 79 (66.9%) 19 (16.1%) 24 (20.3%) 
Emergency 
Medicine 65 5.9% 0 (0.0%) 11 (16.9%) 12 (18.5%) 46 (70.8%) 
All Others  352 32.0% 79 (22.4%) 151 (55.3%) 37 (13.5%) 69 (25.3%) 
Unknown  3 0.3% *Note: Number and Percent of “Prescribers” may be more than Total Responses due 
to overlap in responses. (e.g., a responder who was previously registered with the 
PMP may answer Q6 about current non-enrollment as well as Q8 about previous use 
of PMP. Totals 1,101 100% 
 
*Primary Care Category: Family Medicine/General Practice, Internal Medicine, Obstetrics/Gynecology, Pediatrics. 
*Nursing Category: Advanced Practice Nurse, Family Nurse Practitioner, Nurse Anesthetist, and Nurse Midwife. 
*Dental Category: General and Surgical Dentists 
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RESULTS: SPATIAL PATTERNS OF PRESCRIBING & DISPENSING 
 
Relationships to Areas Outside Maine 
The Maine PMP involves many out-of-state prescribers and patients, representing nearly all U.S. 
states and Canadian provinces.  During FY2008, about 2.3 million prescriptions were filled for narcotic 
analgesics, tranquilizers, and stimulants, serving a patient population of just over .5 million.  PMP 
prescriptions were written by 18,444 licensed prescribers.   
Remarkably, only 5,478 (30%) of the PMP prescribers are located in Maine. However, among 
prescription records for which the prescriber location is known, most of the prescriptions (95%) were 
written by Maine prescribers, and 97% of the unduplicated patients with valid location data are from 
Maine.  Nearly all of the unduplicated pharmacies (98%) reporting to the PMP in FY2008 are located in 
Maine.  The out-of-state patients (n=14,821) come from all other states and Canadian provinces, as do 
the out-of-state prescribers (n=12,966) writing Maine-filled prescriptions (Table 7).   
Not surprisingly, Maine’s neighboring states of New Hampshire and Massachusetts, along with 
Connecticut, Florida, and New York contribute more out-of-state patients than do other states (Figure 2). 
PMP Maps 500-505, which are included in Appendix A, display frequency distributions by states and 
Canadian provinces by fiscal year.  Following the maps are tables displaying the data associated with 
each map.   
The numbers of both in-state and out-of-state patients (Table 2), prescriptions, and prescribers 
have increased every year (Tables 6 and 7). Between FY2007 and FY2008, there was a 9% increase in 
the overall number of prescriptions reported (Table 1), including a 9% increase in the number of 
prescriptions filled for Maine patients (see Tables 6, 7, and 8).  As discussed in the Methods section, we 
were concerned that these increases might be due to improved reporting, so we included an analysis of 
proportions as well as absolute numbers (Table 8). 
   
Table 6.  Number of prescriptions associated with out-of-state patients, prescriptions, and pharmacies 
with valid location data, by fiscal year 
Fiscal Year 
Number of 
Prescriptions 
Dispensed for  
Out-of-State  
PATIENTS 
Number of 
Prescriptions  
Written by  
Out-of-State 
PRESCRIBERS 
Number of 
Prescriptions  
Dispensed by  
Out-of-State 
PHARMACIES 
2005 20,614 186,955 6,586 
2006 21,973 111,005 5,635 
2007 23,173 111,931 6,686 
2008 27,603 113,620 839 
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Table 7.  Number of unduplicated out-of-state patients, prescribers, and pharmacies  
with valid location data, by fiscal year 
Fiscal Year 
Unduplicated  
Out-of-State  
PATIENTS 
Unduplicated  
Out-of-State 
PRESCRIBERS 
Unduplicated  
Out-of-State 
PHARMACIES 
2005 10,700 11,097 15 
2006 11,592 9,623 14 
2007 12,563 11,790 24 
2008 14,821 12,966 7 
 
Table 8. Change in number and percent of PMP data reported from FY2007 to FY2008 
 2007 2008 
Prescriptions reported: all 2,148,294   2,339,662 
Prescriptions reported with 
valid patient locations: total 
• For Maine patients 
• For out-of-state patients 
 
2,147,593 (100.00%) 
2,124,420   (98.89%) 
23,173     (1.08%) 
 
2,339,032 (100.00%) 
2,311,429   (98.79%) 
27,603     (1.18%) 
Unduplicated PATIENTS with 
valid location data: total 
• Maine patients 
• Out-of-state patients 
 
521,812 (100.00%) 
509,249   (97.59%) 
12,563     (1.98%) 
 
562,471 (100.00%) 
547,650   (97.37%) 
14,821     (2.63%) 
Unduplicated PRESCRIBERS 
with valid location data: total 
• Maine prescribers 
• Out-of-state prescribers 
 
19,093 (100.00%) 
7,303   (38.25%) 
11,790   (61.75%) 
 
18,444 (100.00%) 
5,478   (29.70%) 
12,966   (70.30%) 
Unduplicated PHARMACIES 
with valid location data: total 
• Maine pharmacies 
• Out of state pharmacies 
 
310  (100.00%) 
286   (92.26%) 
24     (7.74%) 
 
289  (100.00%) 
282    (97.58%) 
7      (2.42%) 
 
Figure 1 illustrates that, as the total number of unduplicated patients increases overall, so does 
the number of Maine patients.  Figures 2 and 3 show that the volume increase occurs also among 
patients who come from key states (data extracted from Appendix A Table). 
Nevertheless, between FY2007 and FY2008, there were increases in both the number and percent 
of (a) prescriptions for out-of-state patients, (b) unduplicated out-of-state patients, and (c) unduplicated 
out-of-state prescribers (Table 8). The proportion of out-of-state prescribers increased the most, from 
62% to 70%.  The percentage of out-of-state pharmacies, on the other hand, decreased from 8% to 2%.   
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Figure 1. Change in total number of unduplicated patients and number from Maine, by fiscal year 
 
 
 
Figure 2. Number of unduplicated out-of-state patients, by fiscal year and by top five states 
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Figure 3. Number of prescriptions dispensed to patients from top five non-Maine states 
 
 
Locations of (Unduplicated) Patients: Maps 500 and 501 
Maps 500 and 501 and their associated data table, located in Appendix A, (Table Map 500-501) 
presents the number of unduplicated patients (Map 501) and their associated prescriptions (Map 500) 
localized by the patient’s home state or province.  The maps use a gradation to darker colors to indicate 
larger numbers within a state or province. Referring to Table Map 500-501, in FY2008, Maine is home 
to 547,650 (97.3%) of the 562,471 unduplicated patients with valid location data (state or zip code) in 
the PMP, for whom 2,311,429 (98.8%)8 prescriptions were dispensed.  Conversely, 14,821 out-of-state 
patients filled 27,603 prescriptions in Maine during FY2008 (Table 6).   
In all years but FY2005, New Hampshire had the second highest number of Maine’s PMP 
patients, and Massachusetts the third highest (Figure 2).  Referring again to Table Map 500-5001, in 
FY2008, New Hampshire is home to 3,018 (0.5%) unduplicated (“unduplicated”) patients in Maine’s 
PMP, for whom 7,277 (0.3%)9 prescriptions were dispensed.  Massachusetts is home to 2,966 (0.5%), 
with 4,740 (0.2%) prescriptions. Similarly, Florida, ranked fourth, is home to 1,812 (0.3%) unduplicated 
patients in FY2008, for whom 3,673 (0.2%) prescriptions were dispensed.  
 
                                            
8 The totals of patients, prescribers, and prescriptions vary slightly among the separate analyses of spatial data.  This is 
because the number of records with valid location data differs depending on whether patients, prescribers, or pharmacies are 
the analytical focus.  For example, when analyzing the dataset of patients with valid location data, the Maine prescriptions 
account for 98.8% of all the prescriptions, but when analyzing the dataset of prescribers with valid location data, the Maine 
prescriptions account for 95.0% of all prescriptions. 
9 The number of prescriptions for New Hampshire residents increased 26% between FY2007 and FY2008. 
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Locations of (Unduplicated) Prescribers: Maps 502 and 503 
Maps 502 and 503 display the number of unduplicated prescribers (Map 503) and associated 
prescriptions (Map 502) localized by the prescriber’s state.  As in the maps (Appendix A) described 
above, darker colors indicate larger numbers of prescribers and prescriptions within a state.  
Interestingly, the proportion of prescribers and associated prescriptions coming from California, New 
York, and Florida in particular decreased noticeably between FY2005 and FY2008.  Referring to Table 
Map 502-503, in FY2008, Maine is the address of 5,478 (29.7% of 18,444) of the unduplicated 
prescribers with valid location data that appear in the PMP dataset.  Those prescribers are associated 
with 2,162,701 (95.0%) of the 2,276,321 prescription records with valid Prescriber location data. In 
Massachusetts, ranked second in FY2008, there are 3,377 (18.3%) unduplicated prescribers, associated 
with 18,745 (0.8%) prescriptions filled in Maine.  Similarly, in Florida, there are 1,610 (8.7%) 
prescribers and 7,195 (0.3%) prescriptions filled in Maine. New Hampshire is ranked fourth with 1,602 
(8.7%) prescribers and a larger number of prescriptions: 40,547 (1.8%). Thus, as expected, out-of-state 
prescribers each write many fewer prescriptions than prescribers from Maine.   
Location of (Unduplicated) Pharmacies: Maps 504 and 505 
Map 504 displays the number of prescriptions localized by the state of the pharmacies that 
dispensed them for Maine clients.  The pattern has changed with each year.  The number of states 
increased from four in 2007 to seven in 2008, but the number of prescriptions per state has decreased; in 
all states but Maine, pharmacies dispensed a total of fewer than 237 prescriptions.   
Map 505 illustrates the number of unduplicated pharmacies localized by their state.  The table 
associated with Map 504-505 in Appendix A shows that by FY2008 the other states have only one 
pharmacy each, except Florida with two. 
Valid Location Data 
 Table 1 (located in the Methods section) displays the total number of unduplicated patients, 
prescribers, and pharmacies by fiscal year.  With each of these three subsets a slightly different 
percentage of prescription records had valid location data.  Table 2 (Methods section) shows the number 
of prescriptions associated with pharmacies that have valid location data.  These differ slightly from the 
totals for prescribers and patients in FY2008. The dataset had 2,276,321 prescription records for which 
we had complete locations and identification numbers for prescribers. These 2,276,321 prescriptions 
were written by 18,444 unduplicated prescribers (e.g., individual physicians, nurses, dentists). The vast 
majority (95%) of the prescriptions were written by 5,478 Maine-based prescribers.  However, Maine’s 
5,478 prescribers constitute only 29% of the 18,450 total of unduplicated prescribers in the database.  
Thus 71% of the unduplicated prescribers of prescriptions for controlled substances filled in Maine are 
in fact based in states other than Maine.  This pattern reflects the following:  (a) a mostly-seasonal 
influx of non-Maine residents who bring prescriptions from elsewhere; (b) the use by Maine residents of 
health care providers in other states; or (c) prescribers associated with Internet prescribing sites. In 
addition, (d) a small number of physician prescribers, about 10-15 at any one time (according to the 
Director of the Maine Board of Licensure in Medicine) are employed in Maine in temporary locum 
tenens positions, usually substituting for other physicians who are on vacation; many of these physicians 
have out-of-state addresses.   
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 Similarly, in FY2008 (see PMP Map 501), the dataset had 2,339,032 prescription records for 
which we had complete zip code locations and identification numbers for patients.  These 2,339,032 
prescriptions were written for 547,650 unduplicated patients with a Maine zip code.  Maine’s 547,650 
unduplicated patients comprise 97% of the total 562,471 unduplicated patients for whom Maine-filled 
prescriptions were written; 14,821 of the patients were from outside the state.  
Prescribers Lacking Valid Location Data 
 We probed the problem of prescribers who lack valid location data, about 13% of unduplicated 
prescribers (see Table 3).  Did this lack of data occur more with some types of prescriptions than with 
others? We selected four index drugs with relatively high prescription rates with which to perform a 
pilot test:  Adderall XR Cap 20 mg and Methadone Tab 10 mg for C-II, APAP/Codeine Tab 300/30 mg 
for C-III, and Lorazepam Tab 1 mg for C-IV.  We performed a 2 by 2 cross-tabulation using Pearson 
Chi-Square to test statistical significance, comparing each drug with all others in their class in terms of 
whether the prescriber did or did not have valid location data.  Prescribers of Adderall (p<.001), 
APAP/Codeine (p<.001), and Lorazepam (p<.05) are statistically significantly more likely to have 
location data, whereas methadone 10 mg (p<.001) prescribers are statistically significantly less likely to 
have location data.   
We also requested a preliminary analysis of the data quality for DEA numbers.  GHS checked the 
percent invalid DEA# for all the transactions in the 3rd quarter of FY2008; 8.6% were invalid, defined as 
numbers that could not be found in the DEA Federal Feed or the Override table.  This excluded DEA 
numbers for buprenorphine prescriptions, which are masked, and were all considered valid. 
Although these two analyses are very preliminary, their results suggests that more analytical 
attention may need to be given to issues around getting complete prescriber data, particularly given that 
so many of the prescribers are from out-of-state. 
Spatial Analysis of Prescriber Participation in the Online PMP 
 We focused particular attention on the distribution of prescribers who had enrolled to use the 
online PMP, normalized to reflect enrollment rates within Healthy Maine Partnership (HMP) areas. We 
tabulated the number of prescribers enrolled in 2007 and the number enrolled in 2008, according to their 
location.  Rates were adjusted for population density, prescriber density, and prescription density and 
mapped (see Maps 100,109-115 and related tables in Appendix A).  Map 100 is a visual key of the 
Healthy Maine Partnership areas. 
PMP Enrollment Levels: Various Measures 
PMP Map 109 compares the absolute number of prescribers enrolled in 2007, with the number 
enrolled in 2008, displayed as the percent increase or decrease.  The number of enrollees increased in 
most HMP areas, the exception being the St. Croix Valley, which decreased slightly.  The highest 
percent increase is seen in the HMP area associated with Cary Medical Center and the Healthy Peninsula 
HMP located in the Ellsworth-Mt.Desert Island area, both with an increase over 50%. The HMPs in the 
southern quarter of the state had rates around 50%. 
PMP Map 110 compares the 2007 rate of enrollment per 1,000 population with the rate in 2008, 
mapped in HMP areas.  The two maps are shown side by side. The Bangor area shows as the HMP with 
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the highest rate according to population density, and the Augusta-Waterville area is second highest.  
This pattern continues into 2008, when these two areas are joined by the Waldo County HMP.  To the 
extent that areas of greater population density also have a greater density of prescribers, these patterns 
could be anticipated on the basis of population density alone.  However, the Portland area south seems 
to have fewer enrollees in 2007 or 2008, despite its greater population density, and despite the fact that, 
according to Map 109, the number of enrollees had increased. 
PMP Map 111 displays the percent of prescribers who are enrolled in 2008, relative to the total 
number of prescribers who appear in the PMP database.  That is, we used the Maine prescribers of PMP 
drugs in each HMP area as the denominator, and the number of PMP enrollees in each HMP area as the 
numerator.  This map represents the marketing success of the PMP, showing the percentage of the target 
population (providers who prescribe PMP-type controlled substances) have enrolled within each HMP 
area.  Percentages above 50% can be seen in the HMP areas including Wiscasset (Youth Promise), 
Machias, Sebasticook Valley, Dover, Lincoln, and northern Aroostook County.  Lower percentages are 
again seen in the Portland area, as well as the Bangor and Calais areas. 
PMP Map 114 portrays the rate of PMP enrollees per 100,000 prescriptions by HMP area in 
2008.  It shows that the greatest participation, when viewed as a function of prescription density, is in 
the Augusta and Wiscasset areas, with northern Aroostook County and the Ellsworth area second 
highest. 
Levels of Need for the PMP 
PMP Map 112 focuses on the density of prescriptions per 100,000 population, one indication of 
where the need for PMP participation and potential impact is greatest.  The prescription density is 
greatest in the Bangor area, with Waterville and Lewiston-Auburn areas second greatest.  Similarly, 
PMP Map 115 displays the rate of prescribers per 100,000 population.  Again, the Bangor area is 
highest, with Ellsworth and the Portland area second. 
PMP Map 113 focuses on the density of controlled-substance prescribers per 100,000 
prescriptions, an indication of where the potential PMP-participation numbers would be greatest, and 
perhaps where PMP marketing and training might have the greatest pay-off.  The prescriber density is 
greatest in the Kittery area (York Hospital) and the Bangor and Ellsworth areas, indicating fewer 
prescriptions per prescriber, but relatively more prescribers to recruit.  Conversely, recruiting 
prescribers in the Lincoln and Sebasticook areas would impact a greater proportion of prescriptions. 
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RESULTS: SURVEY OF LICENSED PHARMACISTS AND PRESCRIBERS 
Response Rate 
As of July 10, 2009, 1,352 questionnaires had been received: 203 (18.9% of distributed) 
completed the Pharmacist Survey, and 1,101 (20.2% of distributed) completed the Prescriber Licensee 
Survey. Questions in the survey focused on two aspects of the PMP, the threshold reports and the online 
PMP system. 
Pharmacist Survey 
Of the 203 pharmacists who completed the Pharmacist Survey, about half (51.7%) practice in 
pharmacy chains, 21.7% practice in hospitals, and 14.8% are independent (Table 9).  The vast majority, 
192 (94.5%) dispense controlled substances: our analysis focuses on those respondents (Table 10).  Of 
these, 80 (41.7%) pharmacist respondents are registered to use the online PMP.  (OSA listed a total of 
138 enrollees at the time of this survey).  Of the 80 respondents who are registered, 55 (68.7%) 
respondent say they are using the online PMP. 
 Table 9: All Pharmacists: by Practice Specialty (n=203) 
Group and Practice Specialty Number of Respondents Percent 
Chain 105 51.7% 
Other: Hospital 44 21.7% 
Independent 30 14.8% 
Other 13 6.4% 
Other: Long term care 7 3.4% 
Unknown 2 1.0% 
Mail Order 2 1.0% 
A majority of pharmacist respondents (62.5%) have dispensed controlled substances to between 
1% and 50% of their patients over the previous year (Table 10).  The majority of the respondents 
dispense controlled substances either to 1-25% of their patients (24%) or to 26 – 50% of their patients 
(39%). 
Table 10: All Pharmacists: Dispensing of Controlled Substances (n=203) 
 Number of 
Respondents Percent  
Do not dispense controlled substances 11 5.5% 
1%-25% of patients 48 23.6% 
26%-50% of patients 79 38.9% 
51% - 75% of patients 36 17.7% 
76% + of patients 12 5.9% 
Unknown 17 8.4% 
 
 After January 5, 2009, registrants were asked to re-register because of the rollout of a new web 
portal design.  As of July 10, 2009, 17 pharmacists (8.4%) indicate that they have reenrolled since 
January 5, five of whom (2.5%) indicated that they had completed online registration with the PMP both 
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prior to and following January 5.  Results indicate an additional 54 pharmacists (26.6%) whose status is 
unknown (did not answer Question 1b about status), but who had completed registration prior to January 
5.   
Pharmacist Respondents Who Have Not Registered to Use the PMP 
 Respondents who are not registered to use the PMP indicated this by responding to Question 2, 
“I have not registered online with the PMP to request patient history reports.” Almost two-thirds of 
responding pharmacists (63.0%) indicated that they are not currently enrolled with the PMP online 
service.  Of the 128 respondents who are not currently enrolled, 60.9% had never attempted to enroll, 
22.6% do not have internet access at work, 14.1% are unsure how to use the PMP system, and 11.7% 
commented that their own computer network problems and/or organization policy barriers precluded 
their registration (Table 11).  
 
Table 11:  Pharmacists Not Registered: Reasons Cited for Non-Registration with PMP 
multiple choice response (n=128) 
 Number of 
Responses Percent 
Never attempted to enroll 78 60.9% 
Do not have internet access at work 29 22.6% 
Unsure how to use PMP system 18 14.1% 
Other: Is a hospital pharmacist, does not apply 17 13.3% 
Organization policy barriers 9 7.0% 
My network at work did not allow me to use PMP 6 4.7% 
Unsure how I would use information about “doctor shopping 5 3.9% 
Inconvenient to have timely access 4 3.1% 
Do not have an email address that only I can access 4 3.1% 
Other: Did not know about the PMP system 3 2.3% 
Attempted to enroll but PMP crashed my computer 2 1.6% 
Unsure how to use computer  2 1.6% 
Forgot user name or password 1 0.8% 
 
Pharmacist Respondents Who Have Registered But Do Not Use the PMP 
Pharmacist respondents who are registered but do not use the PMP were identified by a positive 
response to Question 3, “I am registered and do not use the PMP to request patient history reports.”  
Twenty-five pharmacists responded. The most common multiple choice reasons cited for being 
registered but not using the PMP were not yet having the opportunity to use it (32%) followed by 
forgetting user name and password (28.%) (Table 12). Organizational barriers and uncertainty about how 
to use the system were each cited by 20% of respondents. 
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Table 12:  Pharmacists Registered/Do Not Use PMP:  
Reasons Cited for Non-Use of PMP Service 
multiple choice response (n=25) 
 Number of 
Responses Percent 
Enrolled but have not yet had the opportunity to use PMP 8 32.0% 
Forgot user name and password 7 28.0% 
Organizational Barriers 5 20.0% 
Unsure how to use PMP 5 20.0% 
Do not have internet access at work 3 12.0% 
Do not have an email address that only I can access 3 12.0% 
System design problems at the PMP’s end 1 4.0% 
Inconvenient to have timely access 1 4.0% 
 
Pharmacist Respondents Who Have Registered and Use the PMP 
  Pharmacist respondents who were registered online with the PMP and use it were identified with 
their response to Question 4, “I am registered and use the PMP to request patient history reports.”  Fifty-
five pharmacists responded.  The most common responses were that they use the service “occasionally” 
in order to check patient history (48.1%), monitor a current patient (67.3%), or check suspicions of 
doctor shopping (50.9%) (Table 13).  Of the 55 respondents, 88.9% state that they use the PMP for 
approximately 1% to 25% of their patients. 
 
Table 13:  Pharmacists Registered/Use PMP:  
in the past year how often have you used the PMP service for the following:  
 Very Rarely/ 
Never Occasionally 
Usually/ 
Always 
To check history for a new patient (n=52) 40.4% 48.1% 11.5% 
To monitor a current patient (n=55) 29.1% 67.3% 3.6% 
To check suspicions of “doctor shopping” (n=49) 24.5% 50.9% 24.5% 
 
For the 55 pharmacists who are or have been registered, when a pharmacist finds through PMP 
that a patient is receiving prescriptions from multiple providers, he/she will “usually/always” look up 
the patient’s history in PMP (62.0%), call prescribers (52.9%), and add the information to the patient’s 
file (52.2%) (Table 14).   
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Table 14. Registered Pharmacists: in the past year how often have you taken the following actions if 
you find that a patient is receiving prescriptions from multiple providers: 
 Very Rarely/ 
Never Occasionally 
Usually/ 
Always 
Call other prescribers listed in PMP (n=51) 19.6% 28.2% 52.2% 
Look up patient history in PMP (n=50) 4.3% 32.6% 63.0% 
Discuss the situation with the patient (n=47) 29.5% 36.4% 34.1% 
Call other pharmacies (n=50) 15.2% 50.0% 34.8% 
Add this information to the patient’s file (n=46) 18.6% 25.6% 62.8% 
 
When asked how the PMP has affected their practice, comments were received from 112 
pharmacist respondents.  The most common response (38.4%) was that the Prescription Monitoring 
Program was a great tool.  Pharmacists used descriptors like “excellent,” “wonderful,” and “invaluable.”  
Of these registered user respondents, 14.3% felt the PMP had done nothing for them, 10.7% would like 
to have access to the program if their employers would allow, and 6.2% registered but have not yet used 
the PMP service. 
Suggestions for improvement were received from 67 pharmacist respondents.  The most common 
responses were: there should be better education about and awareness of the program (16.2%), the new 
interface was too cumbersome and logging in was difficult (16.2%), and make the information more “up-
to-date” (14.7%). 
Reasons for Non-Registration or Non-Use of the PMP by Pharmacists: Further Analysis 
 We examined pharmacy types (chain, independent, and other)10 in terms of PMP registration patterns and 
reasons for non-use of the PMP.   We grouped the reasons respondents selected for not registering with the PMP 
or registering and using the PMP that could be conceivably be mitigated with training, including: inconvenient to 
have timely access; unsure how to use computer; unsure how to use PMP system; and unsure how I would use 
information about doctor shopping.  We grouped two of the reasons for not registering or not using the PMP into 
a category that could be mitigated by design changes, including: system design problems at the PMP’s end and 
forgot user name or password.  And we grouped the following reasons for not registering or not using the PMP 
into an organizational issues category:  organizational policy barriers; attempted to enroll but my network did not 
allow me to use the PMP; do not have internet access at work; do not have an email address that only I can access.   
There is no statistically significant difference among the respondents from these three types of pharmacies 
or in terms of whether pharmacist respondents have ever registered or re-registered, in terms of (a) whether the 
respondent selected organizational issues as a reason for non-use or non-registration, (b) selected training issues, 
or (c) selected design issues.   
 
Selected Pharmacist Key Informant Interviews 
 Three key informant interviews were done with pharmacists representing chains and one 
independent pharmacy to help illuminate survey results.  The individuals interviewed were current PMP 
                                            
10 Hospital pharmacies were removed from this analysis. 
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users.  They stress that organizations differ greatly in their policies and procedures.  None of the three 
reported any policy barriers in their organizations regarding use of the PMP.  Two mentioned that the 
system is not particularly fast to access, as much as 5-6 minutes per patient. Respondents commented 
that using the PMP system required they get out of their organization’s system and onto an internet 
browser, go the PMP site, enter user name and password, wait for verification, enter data about the 
patient they are looking up, wait for the system to make matches, and then review findings, eliminating 
erroneous data matches if present.  They say the new design beginning January 2009 is a bit faster.  The 
second problem, and one for which they see no apparent solution, is that the data are at least two weeks 
old.  Nevertheless they see the PMP as very necessary and helpful.   
Prescriber Survey 
Of the 1,101 respondents who completed the Prescriber Licensee Survey, 974 (88.5%) are 
considered “prescribers”--they had prescribed controlled substances to at least 1% of their patients 
within the previous year.  Table 15 and the associated discussion presents the practice specialty 
frequency distribution and the reported behaviors for prescribers as one population. Following that, we 
have included a section that examines several of the high frequency categories as individual subgroups. 
Family medicine, internal medicine, dentistry, and emergency medicine had the most 
respondents. Of the 156 prescribers who indicated multiple specialties, 30.1% reported a combination of 
Family Medicine/General Practice plus some other specialty. 
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Table 15: Prescribers: Participation by Practice Specialty (n=974) 
Group and Practice Specialty Respondents Percent 
Multiple specialties 156 16.1% 
Family Medicine/General Practice 138 14.2% 
Dentistry, General 92 9.4% 
Internal Medicine 67 6.9% 
Emergency Medicine 58 5.9% 
Family Nurse Practitioner 54 5.5% 
Pediatrics 53 5.4% 
Surgery 51 5.2% 
Psychiatry 47 4.8% 
Orthopedics 44 4.5% 
Obstetrics/Gynecology 25 2.6% 
Dental Surgery 17 1.7% 
Advanced Practice Nurse 17 1.7% 
Other 16 1.6% 
Podiatry 13 1.3% 
Neurology 11 1.1% 
Physical Medicine/Rehab 10 1.0% 
Cardiovascular Diseases 10 1.0% 
Oncology 9 0.9% 
Urology 9 0.9% 
Occupational Medicine 8 0.8% 
Ophthalmology 7 0.7% 
Osteopathic Manipulative Medicine 7 0.7% 
Geriatrics 7 0.7% 
Physician Assistant 6 0.6% 
Other: Palliative care/Hospice 6 0.6% 
Pulmonary Diseases 5 0.5% 
Gastroenterology 5 0.5% 
Anesthesiology 4 0.4% 
Nurse Midwife 4 0.4% 
Other: Rheumatology 4 0.4% 
Unknown 3 0.3% 
Otorhinolaryngology 3 0.3% 
Radiology 3 0.3% 
Other: Endocrinology 3 0.3% 
Addiction Medicine 2 0.2% 
Pain Management 2 0.2% 
Other: Allergy/Immunology 2 0.2% 
Nephrology 1 0.1% 
Dermatology 1 0.1% 
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Of 974 prescribers, 29.9% have been in practice for 1-10 years, 27.3% for 11-20 years, and 
42.8% for more than 20 years. Three-quarters of prescribers (75.2%) prescribe controlled substances to 
between 1% and 25% of their patients (Table 16). 
 
Table 16: Prescribers: Prescription of Controlled Substances Over the Previous Year (n=974) 
 Number of 
Respondents Percent  
1% - 25% of patients 732 75.2% 
26% - 50% of patients 107 11.0% 
51% - 75% of patients 57 5.9% 
76% + of patients 56 5.7% 
Unknown 22 2.3% 
 
Of the 974 prescribers who completed a questionnaire, almost all gave additional information 
about their practice.  A majority of prescriber respondents prescribe for at least some patients with 
anxiety/sleep disorders (83.8%), surgery patients (70.5%), patients with ADD/ADHD (73.9%), cancer 
patients (68.8%), and patients with substance abuse issues (61.1%).  Table 17 presents patient type and 
percent of practice for those respondents who prescribe controlled substances. 
 
Table 17: Prescribers: Percent Patients in Practice, by Category 
 
0% 1%-25% 26%-50% 51%-75% 76% + 
Cancer patients (n=863) 31.2% 63.5% 2.2% 0.9% 2.2% 
Chronic pain patients (n=872) 18.6% 64.6% 10.7% 3.8% 2.4% 
Patients being treated for substance abuse 
(n=855) 38.9% 53.8% 4.2% 1.8% 1.3% 
Patients being treated for anxiety and/or 
sleep disorders (n=877) 16.2% 56.1% 21.4% 4.8% 1.5% 
Patients being treated for ADD/ADHD 
and related disorders (n=865) 26.1% 67.4% 4.7% 0.9% 0.8% 
Surgery patients with post-operative pain 
(n=907) 29.5% 49.1% 7.4% 5.0% 9.0% 
 
 
Medication Threshold Reports 
The PMP sends quarterly notification reports to prescribers when threshold numbers of 
prescribers or pharmacies have been reached or exceeded by any of their patients, or when 
acetaminophen thresholds have been reached.  When asked if they had received medication threshold 
reports, 847 prescribers responded.  Of those, about half (51.9%) had received a PMP threshold 
notification report (Question 3), 40.9% had not, and 7.2% did not know.  
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Table18 outlines actions and frequency for Prescribers who responded to Question 4, “Within the 
past year, how often have you taken the following actions after receiving a patient threshold notification 
report?” More than half of the respondent prescribers will “usually/always” add this information to the 
patient’s file (61.1%) but will “very rarely/never” call other prescribers listed in the threshold report 
(65.3%), discharge the patient from the practice (68.5%), or refer the patient to a licensed substance 
abuse treatment professional (59.8%). Prescribers tend to discuss the situation with the patient usually 
(31.3%) or occasionally (40.3%), or look up patient history in the PMP usually (29.3%) or occasionally 
(38.8%).  About half of the respondents said they establish a controlled substances agreement usually 
(29.8%) or occasionally (19.2%), or conduct a substance abuse screening and brief intervention usually 
(18.5%) or occasionally (28.0%).  
 
Table 18: Prescribers: In the past year how often have you taken the following actions  
after receiving a patient threshold notification report  
 Very Rarely/ 
Never Occasionally 
Usually/ 
Always 
Call other prescribers listed in the threshold report (n=504) 65.3% 29.2% 5.6% 
Look up patient history in PMP (n=516) 32.0% 38.8% 29.3% 
Discuss the situation with the patient (n=581) 28.4% 40.3% 31.3% 
Call the pharmacist(s) (n=507) 43.2% 46.4% 10.5% 
Add this information to the patient’s file (n=525) 19.6% 19.2% 61.1% 
Establish a controlled substances agreement (“narcotics contract”) 
(n=496) 51.0% 19.2% 29.8% 
Conduct a substance abuse screening and brief intervention 
(n=503) 53.5% 28.0% 18.5% 
Refer the patient to a licensed substance abuse treatment 
professional (n=502) 59.8% 33.9% 6.4% 
Discharge the patient from the practice (n=489) 68.5% 31.1% 0.4% 
 
Additional clarifying comments were received from 86 Prescribers.  Most commonly:  the 
prescriber was already aware of the problem (12.7%) or would call the Primary Care Physician (7.6%); 
prescribing had in fact been appropriate (8.9%); the patient in the report was not part of their practice 
(6.3%); or, the reports arrived too late to help/patient had already been discharged (6.3%). 
After January 5, 2009, registrants were asked to reset passwords as part of the rollout of a new 
web portal.  As of July 10, 2009, a total of 134 (13.8%) Prescribers indicated that they are currently 
enrolled. Of those, 83 indicated that they had completed online registration with the PMP both prior to 
and following January 5.  Results also indicate an additional 266 Prescribers (27.3%) whose status is 
unknown (did not answer Question 5b), but who reported completing registration prior to January 5.  
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Prescriber Respondents Who Have Not Registered With the PMP 
Whether or not a prescriber was registered online with the PMP to request patient history reports 
was determined by responses to Question 6, “I have not registered online with the PMP to request 
patient history reports (choose all that apply).” A total of 476 Prescribers responded. Of these, 72.3% 
indicated that they had never attempted to enroll.  Complete responses are presented in Table 19.   
When asked to give “other” reasons for non-registration, 85 Prescribers responded. Of these, 
36.5% did not know or had forgotten about the program and 20.0% felt they would not use it or that it 
did not apply to their practice.  When asked to give additional clarification to PMP system design, 19 
Prescribers responded.  Most (15 respondents) cited login/registration problems in accessing the PMP 
system as the primary reason for non-registration. 
 
Table 19: Prescribers Not Enrolled: Reasons Cited for Non-Registration with PMP  
multiple choice response (n=476) 
 Number of 
Responses Percent 
Never attempted to enroll 344 72.3% 
Unsure how to use PMP system 86 18.1% 
Inconvenient to have timely access 27 5.7% 
Do not have an email address that only I can access 18 3.8% 
Unsure how I would use information about “doctor shopping” 16 3.4% 
Do not have internet access at work 15 3.1% 
System design problems at the PMP’s end 15 3.1% 
Attempted to enroll but PMP crashed my computer 10 2.1% 
Attempted to enroll but my network at work did not allow me to use 
PMP 10 2.1% 
Unsure how to use computer 10 2.1% 
Forgot user name or password 9 1.9% 
Organization policy barriers 7 1.5% 
 
Prescriber Respondents Who Have Registered But Do Not Use PMP 
We used the response to Question 7 (“I am registered and do not use the PMP to request patient 
history reports (choose all that apply)” to identify prescribers who were registered online with the PMP 
but did not use the service.  A total of 160 Prescribers responded.  Of these, 39.4% had forgotten their 
user name and/or password, and 30.0% were unsure how to use the PMP system.  See complete 
responses in Table 20.   
When asked to give “other” reasons for not using the PMP system, 41 Prescribers responded. 
Almost half (41.7%) stated that the PMP did not apply to their practice or they currently have too few 
patients.  When asked to give additional clarification to specific PMP system design issues, 28 
Prescribers responded.  More than three-quarters (78.6%) stated that they had password/login problems 
in accessing the website.   
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Table 20: Prescribers Enrolled/Do Not Use the PMP:  
Reasons Cited for Non-Use of PMP Service 
multiple choice response (n=160) 
 Number of 
Responses 
Percent 
Response 
Forgot user name and password 63 39.4% 
Unsure how to use PMP system 48 30.0% 
Inconvenient to have timely access 40 25.0% 
Enrolled but have not yet had the opportunity to use PMP 33 20.6% 
System design problems at the PMP’s end 26 16.2% 
Do not have internet access at work 6 3.8% 
Do not have an email address that only I can access 6 3.8% 
Unsure how I would use information about “doctor shopping” 3 1.9% 
Unsure how to use computer 2 1.2% 
Organization policy barriers 0 0.0% 
 
Prescriber Respondents Who Are Registered And Use the PMP 
Among respondents to Question 8, a total of 332 Prescribers selected one or more responses 
under “I am registered and use the PMP to request patient history reports (choose all that apply).” Table 
21 presents those Prescriber responses and their frequencies.   
 
 
  
  
Almost all (81.1%) stated that they use the PMP for approximately 1% to 25% of their patients, 
while 9.1% have used it for between 26% and 50% of their patients, and 2.1% have used it for 76% or 
more of their patients. 
The 332 Prescribers who are registered with the PMP and use the online service were asked how 
often they would take a series of actions if they found that a patient was receiving prescriptions from 
multiple user (Table 22). Nearly all respondents add this information to the patient’s file 
”usually/always” (76.1%) or “occasionally (18.9%).  Most respondents choose one or more of the 
actions listed in Table 22, either occasionally or usually, although a majority (54.5%) said they “very 
rarely/never” discharge the patient from the practice.  Of the 37 Prescribers who gave “Other” actions 
Table 21: Prescribers Enrolled/Use the PMP:  
In the past year, how often have you used the PMP service for the following: 
 Very Rarely/ 
Never Occasionally 
Usually/ 
Always 
To check history for a new patient (n=316) 21.5% 44.3% 34.2% 
To monitor a current patient (n=323) 14.6% 61.3% 24.1% 
To check suspicions of “doctor shopping” (n=319) 13.5% 39.2% 47.3% 
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taken, nine (24.3%) respondents stated they discontinued prescribing and six (16.2%) stated they 
contacted or referred back to the Primary Care Physician. 
 
Table 22: Prescribers Enrolled/Use the PMP:  
If you find that a patient is receiving prescriptions from multiple providers, how often do you take the 
following actions  
 Very Rarely/ 
Never Occasionally 
Usually/ 
Always 
Call other prescribers listed in PMP (n=305) 36.4% 43.9% 19.7% 
Look up patient history in PMP (n=305) 7.5% 26.9% 65.6% 
Discuss the situation with the patient (n=325) 5.3% 26.8% 67.7% 
Call the pharmacist(s) (n=312) 30.1% 50.0% 19.9% 
Add this information to the patient’s file (n=318) 5.0% 18.9% 76.1% 
Establish a controlled substances agreement 
(“narcotics contract”) (n=307) 36.8% 19.9% 43.3% 
Conduct a substance abuse screening and brief 
intervention (n=305) 32.1% 36.1% 31.8% 
Refer the patient to a licenses substance abuse 
treatment professional (n=302) 39.1% 48.3% 12.6% 
Discharge the patient from the practice (n=290) 54.5% 39.7% 5.9% 
 
In Question 12, all 974 Prescribers were offered an opportunity to comment on how the PMP had 
affected their practice.  Of 490 Prescriber respondents who commented, 64.5% gave positive responses 
or examples.  Respondents stated the system was “helpful” and “useful.”  Descriptors like “great” and 
“wonderful” were also used. These respondents gave examples like: another good tool, good for 
confirming suspicions of drug abuse, excellent resource, has made practice easier, valuable information, 
gave peace of mind, helpful when confronting a patient, good to know the PMP was there, and it was a 
good resource even when it was not used often.  Additionally, 4.3% did not know the PMP existed or 
had forgotten about it, and 3.9% either look forward to enrolling or have just enrolled.  Of the remaining 
responses, 12.0 % stated it had no or limited effect on their practice and 6.7% stated it did not apply to 
their practice.  
In Question 13, all 974 Prescribers were asked to share any suggestions for improving the 
Prescription Monitoring Program online service (respondents gave multiple responses). Of  229 
Prescriber respondents who commented, the most common responses were: the new interface is 
“clunky,” not “user-friendly,” confusing, hard to navigate, and has too many steps (34.1%); 
login/password accessibility is confusing or frustrating (17.9%); PMP information should be more up-to-
date (17.9%); more training/ information would be beneficial (10.9%); other states should be included 
(3.5%); and methadone clinics should be included (3.9%). Only 2.2% of respondents reported liking the 
new interface. 
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Reasons for Non-Registration or Non-Use of the PMP by Prescribers: Further Analysis 
  
 We looked at whether reasons for non-registration or non-use of the PMP could be associated specifically 
with lack of training, or PMP design, or respondent organization policies.  We found that all three of these types 
of issues were significantly associated with non-registration or non-use.  We also examined how years in practice 
might be associated, and found that those with fewer years in practice were more likely to register and use the 
PMP.  We analyzed whether receiving a threshold report was associated with registration and use, and found that 
it is. 
Training Issues 
 We grouped the reasons for not registering with the PMP or registering and using the PMP that could be 
mitigated with training, including: inconvenient to have timely access; unsure how to use computer; unsure how 
to use PMP system; and unsure how I would use information about doctor shopping.  Respondents who had not 
registered or were not using the PMP were significantly more likely (p < .05) to cite training issues as the reason 
for not registering.  Specifically 16% of ever-registered respondents compared with 21% of non-registered 
respondents cited training issues.  When we compared those who re-registered with those who only said they 
registered in the first round, we found that that the latter group (the ones who did not say they had re-registered) 
was significantly (p=.003) more likely to cite training issues as a reason for not using the PMP: 16% compared 
with 4%. 
Design Issues 
 We grouped two of the reasons for not registering or not using the PMP into a category that could be 
mitigated by design changes, including: system design problems at the PMP’s end and forgot user name or 
password.  Respondents who had never registered were significantly less likely (p < .001) to cite design issues 
than those who had been registered:  4% versus 18% respectively. When we compared those who had re-
registered with those who only said they had registered earlier than January 5 this year, the latter group was more 
likely to cite design issues than those who had re-registered:  19% compared with 5%. 
Organizational Issues  
 We grouped the following reasons for not registering or not using the PMP into an organizational issues 
category:  organizational policy barriers; attempted to enroll but my network did not allow me to use the PMP; do 
not have internet access at work; do not have an email address that only I can access.  Respondents who had ever 
registered were significantly less likely (p < .005) to cite organizational issues at work as a reason for non-use.  
Specifically, 3% of ever-registered compared to 7% of never registered respondents cited organization issues as 
the reason. 
Years in Practice 
Respondents with more years in practice are significantly (p < .001) less likely to have registered or to use 
the PMP.  Whereas 40% of respondents who had been in practice 1-10 years were never registered, 50% of those 
in practice 11-20 years were never registered, and 55% in practice over 20 years were never registered. 
Receiving a Threshold Report 
 There were 346 respondents who had not received a threshold report and 451 who had.  Those who had 
received a threshold report were significantly (p < .001) more likely to register than those who had not:  73% 
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compared to 27%.  Those who had received a threshold report were also significantly (p < .05) more likely to 
have re-registered after January 5, 27% compared to 16%. 
 Registration and Use By Specialty Category 
Of the 1,101 total Prescriber Licensee Survey respondents, 127 (11.5%) do not write scripts for 
controlled substances (“Non-Prescribers”), and 974 respondents have prescribed controlled substances to 
at least 1% of their patients over the past year (“Prescribers”). Categories for Prescriber licensee 
specialties were broken out for further examination:  Primary Care, Nursing, Surgical, Dental, 
Emergency Medicine, and “All Others.”  Unfortunately, although the “all others” category includes 
specialties that are often involved with controlled substances (e.g., pain, psychiatry) there were not 
enough respondents in individual specialties to present them separately.  In comparing differences in 
registration and use of the PMP, Table 23 presents the distribution of questionnaire respondents by 
specialty and by prescriber type.  Note that the frequency distributions in the four columns to the right 
are within the column.  For example, the number of Primary Care respondents who are not registered is 
149, which is 31.4% of the 475 respondent prescribers who are not registered, slightly fewer than the 
34.5% of prescribers in the respondent population as a whole.  Respondents in Primary Care, Nursing, 
and Emergency Medicine are more likely to be registered than would be expected on the basis of the 
specialty frequency distribution among all respondent prescribers. 
Using the raw number frequencies provided in Table 23, we calculated the percentages within 
each specialty category of controlled substance prescribers that are registered: 187 (55.7%) out of 336 in 
Primary Care; 77 of 125 (61.6%) in Nursing; 17 (31.5%) out of 54 Surgical; 39 (33.1%) out of 118 
Dental; and 54 (83.1%) out of 65 Emergency Medicine.  Of those who have registered, the percent of 
those who use the PMP are as follows: Primary Care 68.6%; Nursing 68.3%; Surgical 53.3%; Dental 
55.8%; Emergency Medicine 79.3%.   Emergency Medicine respondents are more likely to be registered 
users than any other category, and years in practice does not make any statistical difference here. 
Among Primary Care respondent prescribers, more than half (55.7%) have registered.  31% have 
never attempted to register, and 9.5% are unsure how to use the PMP. There is no statistically significant 
difference in terms of years in practice. Of the 70 prescribers who offered suggestions, nearly all 
suggested fixing login/password and accessibility problems (program is described as cumbersome), and 
7 recommended having real-time data. 
Among Nursing respondent prescribers, more than half (61.6%) have registered, 21.6% have 
never attempted to register, and 12.0% are unsure how to use the PMP.  There is no significant 
difference in terms of years in practice.  Of the 52 prescribers who offered comments on how the PMP 
had affected their practice, nearly all provided positive statements.  Of the 38 who provided suggestions 
for PMP improvement, 18 commented on fixing login/access problems, and 5 stated real-time 
information would be helpful.  
Surgical and Dental specialties are less likely to be registered PMP users.  The most common 
reason is that they never attempted to enroll or are unsure how to use the PMP.  Additionally, Surgical 
specialties comment on timely access, and Dental specialties comment on unavailability of email or 
internet.   
Surgical specialties prescribe controlled substances to more patients (35.5% prescribe to more 
than half of their patients) than other specialties, but are least likely to use the PMP.  More than half of 
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them have never attempted to enroll, 9.3% are unsure how to use the PMP, and 5.6% say it is 
inconvenient to have timely access.  There is no statistically significant difference in PMP use in terms 
of years in practice. 
Most (66.9%) of Dental specialty respondents have not registered.  More than half (53.4%) have 
never attempted to enroll, 6.8% do not have an email address only they can access, 6.8% are unsure how 
to use the PMP, and 5.9% do not have internet access at work.  There is no statistically significant 
difference in terms of years in practice.   
 
Table 23: All Prescriber Survey Respondents: Distribution of Respondents by Specialty Categories (n=1,101)  
 
   “Prescribers” 
Specialty 
Categories 
Total 
Prescribers 
Percent 
of Total 
Non-Prescribers 
Number/Percent 
Not Registered  
with PMP 
Number/Percent 
Registered/ 
Do Not Use PMP 
Number/Percent 
Registered/ 
Use PMP 
Number/Percent 
Primary Care*  336 34.5% 19 (15.0%) 149 (31.4%) 59 (36.9%) 129 (38.8%) 
Nursing* 125 14.9% 20 (15.7%) 48 (10.1%) 26 (16.2%) 56 (16.9%) 
Surgical  54 5.5% 2   (2.4%) 37   (7.8%) 7   (4.4%) 8   (2.4%) 
Dental* 118 12.1% 7   (5.5%) 79  (16.6%) 19 (11.9%) 24   (7.2%) 
Emergency 
Medicine 65 6.7% 0   (0.0%) 11   (2.3%) 12   (7.5%) 46 (13.9%) 
All Others  273 28.0% 79 (62.2%) 151 (31.8%) 37 (23.1%) 69 (20.8%) 
Unknown 3 0.3% --- --- --- --- 
Total 
Responses 974 100% 127 (100.0%) 475 (100.0%) 160 (100.0%) 332 (100.0%) 
Note: Number of “Prescribers” plus “Non-Prescribers” may be more than Total Responses within a specialty category due to 
overlap in responses. (e.g., a responder who was previously registered with the PMP may answer Q6 about current non-
enrollment as well as Q8 about previous use of PMP. 
*Primary Care Category: Family Medicine/General Practice, Internal Medicine, Obstetrics/Gynecology, Pediatrics. 
*Nursing Category: Advanced Practice Nurse, Family Nurse Practitioner, Nurse Anesthetist, and Nurse Midwife. 
*Dental Category: General and Surgical Dentists 
 
Non-Prescribers by Specialty Category 
Of the 1,101 Prescriber Licensee Survey respondents, 127 (11.5%) do not prescribe controlled substances 
(“Non-Prescribers”). Within each specialty group: 2 (3.6%) of Surgical, 7 (5.6%) of Dental, 19 (5.3%) of Primary 
Care, 20 (13.8%) of Nursing, and 79 (22.4%) of “All Others” do not write scripts for controlled substances.  All 
Emergency Medicine respondents have prescribed to at least 1% of their patients over the previous year. 
Prescriber Registration Types by Specialty Category 
Table 24 provides the frequency with which Prescribers within each specialty category write 
scripts for controlled substances.  Most surgeons (77.9%) tend to prescribe controlled substances for 
more than 25% of their patients.  Most primary care specialists (87.5%), on the other hand, report 
prescribing controlled substances for only 1%-25% of their patients. 
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Table 24: Prescribers: Dispensing of Controlled Substances Over the Previous Year 
 0% 
of patients 
1%-25% 
of patients 
26%-50% 
of patients 
51%-75% 
of patients 
76% + 
of patients 
Primary Care (n=330) - 87.5% 7.7% 1.5% 1.5% 
Nursing (n=125) - 76.0% 10.4% 8.0% 5.6% 
Surgical (n=53) - 32.1% 26.4% 24.5% 11.0% 
Emergency Medicine (n=63) - 74.6% 15.9% 9.5% 0.0% 
Dental (n=115) - 86.1% 4.3% 3.5% 6.1% 
All Others (n=264) - 67.8% 14.4% 7.2% 10.6% 
 
Respondents were asked whether or not they had received a PMP threshold notification report 
within the previous year (Table 25).  Emergency medicine respondents (74.6%) were most likely to say 
they had received a report while Dental specialty respondents (35.1%) were least likely. 
 
 
Table 25: Prescribers: Have you received a patient threshold report in the past year 
 Yes No Don’t Know 
Primary Care (n=332) 54.2% 37.7% 8.1% 
Nursing (n=122) 45.1% 50.0% 4.9% 
Surgical (n=52) 63.5% 26.9% 9.6% 
Emergency Medicine (n=63) 74.6% 19.0% 6.3% 
Dental (n=114) 35.1% 60.5% 4.4% 
All Others (n=262) 52.3% 39.7% 8.0% 
 
Prescriber respondents were asked if they are registered and use the PMP online service.  
Responses are presented below in three groups: “Have not registered with the PMP,” “Registered and do 
not use the PMP,” and “Registered and use the PMP.”  Table 25 above presents distribution of responses 
for these three categories. 
Prescribers Who Are Not Registered With the PMP, by Specialty Category 
Of Prescriber respondents who write scripts for controlled substances, 149 (44.3%) of primary 
care, 48 (38.4%) of nursing, 37 (68.5%) of surgical specialties, 11 (16.9%) of emergency medicine, 79 
(66.9%) of dental, and 151 (55.3%) of “All Other” respondents gave reasons for non-registration with 
the PMP.  As presented in Table 26, those in Surgical specialty were more likely (83.8%) to say they 
had never attempted to enroll compared to those in Emergency medicine (36.4%). Those in Nursing 
specialties (31.3%) and Emergency Medicine (27.3%) were more likely to state they were unsure how to 
use PMP as a reason for non-registration than those in Surgical (13.5%) or Dental (10.1%) specialties. 
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Table 26: Prescribers Not Enrolled:  
Reasons Cited for Non-Registration with PMP, by Specialty (multiple choice) 
 Primary 
Care 
n= 149 
Nursing 
n=48 
Surgical 
n=37 
Emergency 
Medicine 
n=11 
Dental 
n=79 
All Others 
n=151 
Have not attempted to enroll 69.8% 56.3% 83.8% 36.4% 76.7% 76.2% 
Attempted to enroll but PMP crashed 
my computer 2.0% 2.1% 0% 18.2% 1.3% 2.0% 
Attempted to enroll but my network at 
work did not allow me to use PMP 0.7% 10.4% 0% 9.1% 0% 2.0% 
Organization policy barriers 0.7% 0% 5.4% 9.1% 2.5% 0.7% 
System design problems at the PMPs 
end 4.7% 2.1% 0.0% 27.3% 1.3% 2.0% 
Forgot user name or password 2.7% 2.1% 0.0% 0.0% 1.3% 2.0% 
Inconvenient to have timely access 5.4% 4.2% 8.1% 18.2% 7.6% 4.0% 
Unsure how to use computer 2.0% 0% 0% 9.1% 3.8% 2.0% 
Do not have internet access at work 2.0% 2.1% 0% 0% 8.9% 2.6% 
Do not have an email address that only 
I can access 3.4% 4.2% 2.7% 0.0% 10.1% 1.3% 
Unsure how to use PMP 21.5% 31.3% 13.5% 27.3% 10.1% 15.2% 
Unsure how I would use information 
about “doctor shopping” 1.3% 2.1% 5.4% 0% 5.1% 4.6% 
 
Prescribers Who Are Registered With the PMP But Do Not Use It, by Specialty Category 
Of Prescribers, 59 (17.6%) of primary care, 26 (20.8%) of nursing, 7 (13.0%) of surgical 
specialties, 12 (18.5%) of emergency medicine, 19 (16.1%) of dental, and 37 (13.5%) of “All Other” 
Prescribers cited reasons for being registered but not using the PMP.   
Reasons cited by enrolled Prescribers for not using the online service are presented in Table 27.  
The most common reasons cited by 52.5% of Primary Care and 58.3% of Emergency Medicine 
specialties were “forgot user name or password.” This reason is also relatively high in frequency among 
Nursing (28.5%) and Dental (26.3%) categories. For Surgical specialties (42.9%) and Emergency 
Medicine (41.7%) the most common reason was “inconvenient to have timely access.” This reason is 
also relatively high in frequency for the Nursing category (34.6%). For Dental specialties, (36.8%) it 
was “enrolled but have not yet had the chance to use the PMP.  Of the 25 respondents who gave 
qualitative comments to expand on “system design problems at the PMPs end,” 76.0% cited login or 
access problems as the reason for not using the PMP service. 
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Table 27: Prescribers Enrolled/Do Not Use PMP:  
Reasons Cited for Non-use of PMP, by Specialty (multiple choice) 
 Primary 
Care 
n= 59 
Nursing 
n=26 
Surgical 
n=7 
Emergency 
Medicine 
n=12 
Dental 
n=19 
All Others 
n=37 
Organization policy barriers 0% 0% 0% 0% 0% 0% 
Do not have internet access at work 0% 3.8% 0% 0% 15.8% 5.4% 
Do not have an email address that only 
I can access 3.4% 7.7% 0% 0% 5.3% 2.7% 
System design problems at the PMPs 
end 20.3% 7.7% 0% 25.0% 31.6% 8.1% 
Forgot user name or password 52.5% 38.5% 14.3% 58.3% 26.3% 24.3% 
Inconvenient to have timely access 20.3% 34.6% 42.9% 41.7% 21.1% 18.9% 
Unsure how to use computer 1.7% 0% 0% 0% 5.3% 0% 
Unsure how to use the PMP system 25.4% 38.5% 0% 16.7% 10.5% 51.4% 
Unsure how I would use information 
about “doctor shopping” 1.7% 3.8% 11.3% 0% 0% 0% 
Enrolled but have not yet had the 
opportunity to use PMP 5.1% 30.8% 28.6% 0% 36.8% 35.1% 
 
Prescribers Who Are Registered With the PMP And Use It, by Specialty Category 
 Whether or not a prescriber was registered with the PMP and uses this online service was 
determined by responses to Question 8, “I am registered and use the PMP to request patient history 
reports (choose all that apply).”  Details about the frequency of on-line PMP use were provided by 129 
(38.4%) of Primary Care, 56 (44.8%) of Nursing, 8 (14.8%) of Surgical specialties, 46 (70.8%) of 
Emergency Medicine, 24 (20.3%) of Dental specialties, and 69 (25.3%) of “All Other” respondents (see 
Tables 28-30).  A substantial proportion of Nursing (44.4%), Emergency Medicine (45.0%), and Primary 
Care (36.5%) respondents report “usually/always” using it to check history for a new patient, whereas 
fewer of those in the Surgical (25.0%) and Dental (0%) specialties do so.   
 
Table 28: Prescribers Enrolled/Use the PMP: 
 How often have you used the PMP to check history for a new patient  
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=126) 17.5% 46.0% 36.5% 
Nursing (n=54) 18.5% 37.0% 44.4% 
Surgical (n=8) 50.0% 25.0% 25.0% 
Emergency Medicine (n=40) 5.0% 50.0% 45.0% 
Dental (n=23) 60.9% 39.1% 0% 
All Others (n=65) 24.6% 47.7% 27.7% 
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Table 29: Prescribers Enrolled/Use the PMP:  
How often have you used the PMP to monitor a current patient 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=129) 7.0% 66.7% 26.4% 
Nursing (n=56) 14.3% 50.0% 35.7% 
Surgical (n=8) 37.5% 50.0% 12.5% 
Emergency Medicine (n=40) 32.5% 40.0% 27.5% 
Dental (n=23) 34.8% 60.9% 4.3% 
All Others (n=67) 9.0% 74.6% 16.4% 
 
 
Table 30: Prescribers Enrolled/Use the PMP:  
 How often have you used the PMP to check suspicions of “doctor shopping” 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=127) 11.0% 40.2% 48.8% 
Nursing (n=55) 10.9% 34.5% 54.5% 
Surgical (n=8) 37.5% 37.5% 25.0% 
Emergency Medicine (n=42) 4.8% 31.0% 64.3% 
Dental (n=22) 36.4% 36.4% 27.3% 
All Others (n=65) 15.4% 47.7% 36.9% 
 
 
Most of the PMP users report occasional use, rather than routine use for current patients (Table 
33).  Respondents in the Primary Care (48.8%), Nursing (54.5%) and Emergency Medicine (64.3%) are 
likely to use the PMP “usually/always” to check suspicions of “doctor shopping,” although fewer 
respondents in the Dental (25.0%) and Surgical (25.0%) specialties do (Table 34).  Most PMP users in 
all specialties report they use the system for “1% - 25%” of their patients (Table 35). 
 
 
Table 31: Prescribers Enrolled/Use the PMP:  
Within the past year, for approximately what percent of your patients have you used the PMP service? 
 0% 
of patients 
1%-25% 
of patients 
26%-50% 
of patients 
51%-75% 
of patients 
76% + 
of patients 
Primary Care (n=127) 0.8% 92.1% 5.5% 0.8% 0.8% 
Nursing (n=54) 7.4% 74.1% 11.1% 1.9% 5.6% 
Surgical (n=8) 12.5% 62.5% 25.0% 0% 0% 
Emergency Medicine (n=45) 0% 84.4% 15.6% 0% 0% 
Dental (n=23) 17.4% 78.3% 4.3% 0% 0% 
All Others (n=67) 3.0% 79.1% 11.9% 1.5% 4.5% 
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332 on-line PMP users responded to the question about actions taken as a result of PMP 
threshold report information that their patient is “receiving prescriptions from multiple providers.  
Tables 32-40 present their responses by practice specialty. 
1. More prescribers in the Primary Care and Nursing specialties are likely to “occasionally” or 
“usually/always” call other prescribers compared to Surgical, Emergency Medicine, or Dental 
specialties (Table 32). 
 
Table 32: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you… Call other Prescribers Listed in the PMP 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=118) 29.7% 44.1% 26.3% 
Nursing (n=49) 30.6% 51.0% 18.4% 
Surgical (n=8) 50.0% 50.0% 0% 
Emergency Medicine (n=40) 60.0% 35.0% 5.0% 
Dental (n=20) 60.0% 25.0% 15.0% 
All Others (n=62) 25.8% 53.2% 21.0% 
 
2. While a majority of surgical specialty respondents (62.0%) will look up a patient history in PMP 
“occasionally,” respondents in other specialties say they “usually/always” do so (range: 62.1% to 
78.4%) (Table 33). 
 
Table 33: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you… Look up Patient History in PMP 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=120) 4.2% 30.0% 65.8% 
Nursing (n=51) 7.8% 13.7% 78.4% 
Surgical (n=8) 12.5% 62.5% 25.0% 
Emergency Medicine (n=40) 7.5% 27.5% 65.0% 
Dental (n=20) 15.0% 15.0% 70.0% 
All Others (n=58) 8.6% 29.3% 62.1% 
 
3. More respondents in the Nursing (80.0%) and Primary Care (75.2%) specialties “usually/always” 
discuss the situation with the patient compared with Dental specialties (30.0%) (Table 34). 
 
Table 34: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you…  Discuss the Situation with the Patient 
 Margaret Chase Smith Policy Center, Analysis of PMP Participation, 2009    41   
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=125) 3.2% 21.6% 75.2% 
Nursing (n=55) 3.6% 16.4% 80.0% 
Surgical (n=8) 12.5% 37.5% 50.0% 
Emergency Medicine (n=44) 4.5% 43.2% 52.3% 
Dental (n=20) 30.0% 40.0% 30.0% 
All Others (n=65) 3.1% 29.2% 67.7% 
 
4. Most respondents in the Primary Care (74.8%) and Nursing (82.7%) categories say they either 
“occasionally” or “usually/always” call the pharmacist, whereas fewer in Surgical (57.2%), Dental 
(55.0%), or Emergency Medicine (58.5%) specialties do (Table 35).  
 
Table 35: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you… Call the Pharmacist(s) 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=123) 25.2% 56.1% 18.7% 
Nursing (n=52) 17.3% 51.9% 30.8% 
Surgical (n=7) 42.9% 42.9% 14.3% 
Emergency Medicine (n=41) 58.5% 34.1% 7.3% 
Dental (n=20) 45.0% 20.0% 35.0% 
All Others (n=61) 29.5% 54.1% 16.4% 
 
5. Primary Care, Nursing, and Surgical specialists are much more likely to add a threshold report to the 
patient’s file (Table 36).   
 
Table 36: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you… Add this Information to the Patient’s File 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=124) 0.8% 14.5% 84.7% 
Nursing (n=51) 3.9% 11.8% 84.3% 
Surgical (n=8) 0% 25.0% 75.0% 
Emergency Medicine (n=42) 14.3% 42.9% 42.9% 
Dental (n=20) 25.0% 20.0% 55.0% 
All Others (n=65) 1.5% 16.9% 81.5% 
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6. A majority of respondents in the Primary Care (62.5%) and Nursing (64.7%) specialties report 
they “usually/always” establish a controlled substances agreement with a patient who is receiving 
prescriptions from multiple providers, whereas Dental (100.0%) and Emergency Medicine 
(95.1%) specialties “very rarely/never” do so (Table 37).   
 
Table 37: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you… Establish a Controlled Substances Agreement 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=120) 12.5% 25.0% 62.5% 
Nursing (n=51) 11.8% 23.5% 64.7% 
Surgical (n=7) 57.1% 28.6% 14.3% 
Emergency Medicine (n=41) 95.1% 2.4% 2.4% 
Dental (n=19) 100.0% 0% 0% 
All Others (n=61) 42.6% 24.6% 32.8% 
7. Not surprisingly, many more respondents in the Primary Care (81.6%) and Nursing (89.8%) 
specialties conduct a substance abuse screening and intervention compared to Surgical (14.3%) or 
Dental (5.3%) specialties (Table 38).  Similarly, more Primary Care (68.6%) and Nursing (82.0%) 
respondents refer a patient to a licensed substance abuse treatment professional (Table 39). 
 
Table 38: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you…  
Conduct a Substance Abuse Screening and Brief Intervention 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=119) 18.5% 42.9% 38.7% 
Nursing (n=49) 10.2% 46.9% 42.9% 
Surgical (n=7) 95.7% 14.3% 0% 
Emergency Medicine (n=31) 50.0% 35.7% 14.3% 
Dental (n=18) 94.7% 5.3% 0% 
All Others (n=59) 34.4% 27.9% 37.7% 
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Table 39: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you… 
Refer the Patient to a Licensed Substance Abuse Treatment Professional 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=121) 31.4% 56.2% 12.4% 
Nursing (n=50) 18.0% 54.0% 28.0% 
Surgical (n=7) 57.1% 28.6% 14.3% 
Emergency Medicine (n=41) 56.1% 39.0% 4.9% 
Dental (n=19) 94.7% 5.3% 0% 
All Others (n=56) 39.3% 51.8% 8.9% 
 
8. Most respondents in Emergency Medicine (93.5%) and Dental (77.8%) specialties will “very 
rarely/never” discharge the patient from their practice, while more respondents in other specialties 
reported “very rarely” or “occasionally” doing so (Table 40). 
 
Table 40: Prescribers Enrolled/Use the PMP: If you find that a patient is receiving  
prescriptions from multiple providers, how often do you… 
Discharge the Patient from the Practice 
 Very 
Rare/Never Occasionally 
Usually/ 
Always 
Primary Care (n=120) 43.3% 50.0% 6.7% 
Nursing (n=46) 41.3% 41.3% 17.4% 
Surgical (n=8) 62.5% 37.8% 0% 
Emergency Medicine (n=31) 93.5% 6.5% 0% 
Dental (n=18) 77.8% 16.7% 5.6% 
All Others (n=59) 59.3% 40.7% 0% 
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CONCLUSIONS AND RECOMMENDATIONS
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PMP MAP 100: HEALTHY MAINE PARTNERSHIPS 
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Medical Center Names
®v AROOSTOOK MEDICAL CENTER - COMMUNITY GENERAL DIVISION, FORT FAIRFIELD
®v AROOSTOOK MEDICAL CENTER, PRESQUE ISLE
®v CENTRAL MAINE MEDICAL CENTER, LEWISTON
®v EASTERN MAINE MEDICAL CENTER, BANGOR
®v MAINE MEDICAL CENTER, PORTLAND
®v MAINEGENERAL MEDICAL CENTER SETON DIVISION, WATERVILLE
®v MAINEGENERAL MEDICAL CENTER THAYER DIVISION, WATERVILLE
®v MAINEGENERAL MEDICAL CENTER, AUGUSTA
®v NORTHERN MAINE MEDICAL CENTER, FORT KENT
®v PENOBSCOT BAY MEDICAL CENTER, ROCKPORT
®v SAINT MARYS REGIONAL MEDICAL CENTER, LEWISTON
®v SOUTHERN MAINE MEDICAL CENTER, BIDDEFORD
®v TOGUS VETERANS ADMINISTRATION MEDICAL CENTER, AUGUSTA  
 
ID# Healthy Maine Partnership Lead Agency 
1 Unincorporated of Unenrolled  
2 ACCESS Health Mid Coast Hospital 
3 Aroostook County Action Program Aroostook County Action Program 
4 Bangor Healthy & Welfare Bangor Health & Welfare 
5 Bucksport Bay Healthy Communities Coalition Town of Bucksport 
6 Cary Medical Center Cary Medical Center 
7 Choose to be Healthy, York Hospital York Hospital 
8 Coastal Healthy Communities Coalition, UNE University of New England 
9 Greater Somerset Public Health Collaborative Redington-Fairview General Hospital 
10 Greater Waterville PATCH Greater Waterville PATCH 
11 Health Androscoggin Central Maine Community Health Corp. 
12 Health Oxford Hills Western Maine Health 
13 Healthy Acadia Acadia Community Association 
14 Healthy Casco Bay (HMP 2) City of Portland 
15 Healthy Communities of the Capitol area Health Communities of the Capitol area 
16 Healthy Community Coalition Franklin Community Health Network 
17 Healthy Peninsula Child and Family Opportunities 
18 Healthy Portland (HMP 1) City of Portland 
19 Katahdin Shared Services Katahdin Shared Services 
20 Knox County Community Health Coalition Penobscot Bay YMCA 
21 Lakes Region (HMP 1) People's Regional Opportunity Program 
22 Partners for Healthier Communities, Goodall Hospital Goodall Hospital, Inc. 
23 Piscataquis Public Health Council Mayo Regional Hospital 
24 River Valley Healthy Communities Coalition River Valley Healthy Communities Coalition 
25 Rivers Region (HMP 2) People's Regional Opportunity Program 
26 
Sebasticook Valley Healthy Communities Coalition 
(Comb.) Sebasticook Valley Hospital 
27 St. Croix Valley Healthy Communities Downeast Health Services 
28 Union River Healthy Communities Downeast Health Services 
29 Waldo County CCHC Waldo County General Hospital 
30 Washington County: One Community Washington County 
31 Youth Promise Youth Promise 
Table Map 100 
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